Open Access Article
This Open Access Article is licensed under a Creative Commons Attribution-Non Commercial 3.0 Unported Licence

Recovery of bioactive plant compounds from biomass waste using sustainable methods: a review

Edgar I. Juárez-Robles a, Rodrigo Barrón-Velázquez a, Mariana Macías-Alonso *a, Rosa Hernández-Soto a, Iván Córdova-Guerrero b and Joaquin G. Marrero *a
aInstituto Politécnico Nacional, Unidad Profesional Interdisciplinaria de Ingeniería Campus Guanajuato, Av. Mineral de Valenciana 200 Col. Fracc. Industrial Puerto Interior, Silao 36275, Mexico. E-mail: mmacias@ipn.mx; jgonzalezm@ipn.mx
bFacultad de Ciencias Químicas e Ingeniería, Universidad Autónoma de Baja California, Tijuana 22390, Mexico

Received 22nd August 2025 , Accepted 10th May 2026

First published on 11th May 2026


Abstract

The circular bioeconomy promotes the sustainable use of renewable biomass to enhance resource efficiency and reduce environmental impacts. In this context, residual plant biomass is an underutilised feedstock rich in high-value bioactive phytochemicals, including terpenes, phenolic compounds, and nitrogen-containing metabolites, with applications in the food, cosmetic, nutraceutical, and pharmaceutical sectors. However, their selective recovery remains challenging due to the complexity of plant matrices and the technical, economic, and environmental constraints of conventional extraction processes. This review critically examines recent advances in green extraction and purification technologies for the recovery of bioactive secondary metabolites from agricultural and medicinal plant residues. Environmentally benign and intensified methodologies—such as supercritical fluid extraction, deep eutectic solvents, microwave- and ultrasound-assisted extraction, and enzyme-assisted processes—are discussed with emphasis on matrix-dependent behaviour, scalability limitations, and integration potential within biorefinery frameworks. Techno-economic aspects, including capital and operational costs, industrial feasibility, and broader environmental, circularity, and societal considerations, are also addressed. Overall, this review provides a balanced perspective on the opportunities and limitations of sustainable bioactive recovery pathways.


image file: d5su00695c-p1.tif

Edgar I. Juárez-Robles

Edgar I. Juárez-Robles is a graduate student at the Instituto Politécnico Nacional (IPN), Mexico, where he also earned his degree in Biotechnology Engineering, graduating with distinction. He served as a research assistant for 18 months in the Laboratory of Organic Chemistry and Pharmacognosy under the supervision of Dr Joaquín G. Marrero and Dr Mariana Macías Alonso, an experience that strengthened his technical expertise in the synthesis, characterisation, and analysis of natural and bioactive compounds. His research background includes the valorisation of lignocellulosic residues, with initial work focused on delignification processes and the sustainable transformation of biomass into value-added chemical products. Through this work, he developed a strong interest in green chemistry, biomass valorisation, and circular bioeconomy strategies. His current research interests lie at the interface of natural products chemistry and sustainable bioprocesses, with an emphasis on the development of environmentally responsible methodologies for the recovery and modification of bioactive compounds.

image file: d5su00695c-p2.tif

Rodrigo Barrón-Velázquez

Rodrigo Barrón Velázquez is a Biotechnology Engineer who graduated from the Instituto Politécnico Nacional (IPN), Mexico, in 2025. His academic training has provided him with a strong foundation in molecular biology, genetics, and microbiology, complemented by practical experience in bioconversion processes and the production of secondary metabolites through both solid-state and liquid fermentations. He is currently pursuing postgraduate studies in Natural Products under the supervision of Dr Mariana Macías Alonso and Joaquín G. Marrero, where his research focuses on the synthesis of bioactive compounds isolated from natural sources, with potential applications in pharmaceutical, nutraceutical, and biotechnological fields.

image file: d5su00695c-p3.tif

Mariana Macías-Alonso

Mariana Macías Alonso is a chemist with a PhD in Chemical Sciences and over a decade of experience in organic chemistry and natural products chemistry, with a strong focus on sustainable chemical transformations of bio-based molecules. Her research addresses the design, synthesis, and functionalisation of naturally derived compounds, integrating principles of green chemistry, bioeconomy, and process sustainability. Her work includes studies on pericyclic reactions, particularly Diels–Alder cycloadditions applied to bioinspired and natural product synthesis, as well as the chemical modification of plant-derived metabolites and biomass-derived intermediates. In parallel, she investigates chemical and enzymatic strategies for biomass valorisation, including the transformation of agro-industrial by-products into value-added chemicals for applications in agriculture, materials, and health-related sectors. She has led competitive research projects supported by academic institutions, governmental agencies, and industry, resulting in peer-reviewed publications and applied chemical developments. She is a Level I member of the National System of Researchers (SNII) and actively contributes to knowledge transfer and sustainable chemistry dissemination, promoting the role of chemistry as a key driver of industrial and environmental sustainability.

image file: d5su00695c-p4.tif

Rosa Hernández-Soto

Rosa Hernández-Soto received her PhD from the Research and Assistance Center in Technology and Design of the State of Jalisco in the field of agro-industrial processes. She was appointed a full Professor at the Instituto Politécnico Nacional of México in 2010. Her research aims to obtain bioactive compounds from agro-industrial waste.

image file: d5su00695c-p5.tif

Iván Córdova-Guerrero

Dr Iván Córdova Guerrero is an industrial chemist at the Universidad Autónoma de Baja California (UABC), Mexico, and holds a PhD in chemical sciences from the Instituto Universitario de Bio-Orgánica “Antonio González” in Tenerife, Spain. He is currently a professor and researcher at UABC, where he leads academic and research programs in agrochemistry, natural products, and sustainable agriculture. His research focuses on plant biostimulation and developing eco-friendly agricultural inputs to improve crop resilience and support native species under abiotic stress conditions. Dr Córdova's expertise includes formulating agricultural products, analysing plant nutrition, and developing experimental methods for assessing bioactive natural compounds. He has contributed to interdisciplinary projects on sustainable viticulture, ecological restoration, and valorising residual biomass through the synthesis of bioactive compounds. He is the Head of the Laboratory of Phytoagrochemical Research, overseeing studies on bioactive molecules of agricultural interest and the development of biostimulants, fertilisers, and natural pesticides. Additionally, he collaborates closely with the agro-industrial sector as an innovation and product development advisor at Agrobioma Sonora, Mexico, contributing to the design of precision-formulated agrochemical solutions. Dr Córdova has published scientific papers, book chapters, and conference presentations at both national and international levels. He has served as a Visiting Professor at the University of California, San Diego, and is a Level II member of Mexico's National System of Researchers (SNI). His professional career combines science, technology, and Environmental efforts to promote sustainable innovation in agriculture and biodiversity conservation.

image file: d5su00695c-p6.tif

Joaquin G. Marrero

Joaquín G. Marrero is a Professor of Chemistry at the National Polytechnic Institute (IPN), Mexico, where he has held a permanent academic position since 2010. He obtained his PhD in Chemistry from the Antonio González Bio-Organic Institute at the University of La Laguna, Spain, after completing his undergraduate and postgraduate studies in Chemistry at the same institution. His academic career includes postdoctoral research appointments at the University of Reading (UK) and the National Autonomous University of Mexico (UNAM), as well as previous academic and industrial positions in Mexico and Europe. He is currently a Senior Level II Fellow of the National System of Researchers (SNI) and a Member of the Royal Society of Chemistry. His research focuses on organic synthesis, natural product chemistry, Diels–Alder cycloaddition reactions, biomass valorisation, and the development of bioactive compounds for pharmaceutical, agricultural, and industrial applications within a circular bioeconomy framework. He has led and co-led numerous competitive research projects funded by national and industrial agencies, authored more than 25 peer-reviewed scientific publications and several book chapters, and actively contributes to the scientific community as a reviewer and member of international evaluation committees.



Sustainability spotlight

Agricultural and industrial biomass residues are generated in large quantities and, when underutilised, drive waste accumulation and environmental burdens. Simultaneously, conventional extraction processes still rely on fossil-derived solvents, perpetuating unsustainable production. Tackling both issues is crucial to reducing waste and promoting renewable alternatives. This review showcases sustainable advances in recovering high-value bioactive compounds through green solvents, solvent recyclability, and integrated biorefinery strategies, offering scalable and cleaner pathways than traditional methods. These innovations valorise waste, enhance resource efficiency, and minimise chemical hazards. The work aligns with UN SDG 12 (responsible consumption and production) and SDG 9 (industry, innovation, and infrastructure) by fostering circular economy models, while also contributing to SDG 3 (Good Health and Well-being) and SDG 13 (Climate Action).

1 Introduction

Since the Second Industrial Revolution, human activity has exerted profound pressure on the environment, accelerating climate change and biodiversity loss. At the core of this environmental degradation lies a predominantly linear economic model that, although key to improving quality of life, has come at the cost of depleting finite natural resources.1

By contrast, the circular economy offers an alternative model that seeks to redefine growth by decoupling economic activity from the consumption of limited resources.2,3 Within this framework, residual biomass has emerged as a renewable feedstock rich in phytochemicals with high functional and market value, offering bio-based substitutes for fossil-derived ingredients in the pharmaceutical, cosmetic, and food industries, and occupying a unique position among renewable sources for its capacity to supply energy while enabling the production of biobased products.4 Globally, about 181.5 billion tonnes of waste biomass are produced annually, but only 8.2 billion tonnes of lignocellulosic biomass are currently used.5 Among these resources, medicinal and aromatic plants (MAPs) stand out for their biochemical diversity and for producing approximately 330 million tonnes of residues annually from essential oil and herbal processing.6 These residues represent a source of bioactive molecules that could support a transition toward sustainable value chains.

Phytochemicals are naturally occurring compounds commonly grouped into three major classes: terpenes, phenolic and nitrogen-containing compounds.7 Recovering these molecules from biomass by-products both valorises waste and supports carbon neutrality,8 advancing climate targets by supplying renewable carbon feedstocks.9

The sustainable development and utilisation of plant extracts and natural products offer a significant opportunity to strengthen the global bioeconomy, particularly in developing regions where biodiversity and agricultural residues are abundant. These natural compounds play crucial roles in four interrelated sectors of high socio-economic impact: food ingredients, flavouring agents and spices, perfumes and cosmetics, and pharmaceuticals.10 Notably, between 1981 and 2019, approximately 60% of newly approved drugs were either natural products, derivatives, or synthetic mimetics inspired by natural structures, underscoring the continued relevance of nature-based solutions.11

Despite recent progress, the extraction, fractionation, and purification of phytochemicals from biomass remain technically challenging, often involving solvent-intensive, energy-demanding processes that are difficult to scale.12 The development of green and selective extraction technologies is therefore essential to unlock the full potential of biomass within a circular bioeconomy. Recent studies have increasingly focused on such valorisation strategies, emphasising environmentally benign processes tailored to specific biomass matrices.13

Within this context, this review provides a focused overview of recent advances in green extraction and purification of secondary metabolites from plant-based residual biomass. It highlights environmentally sustainable, selective, and scalable methodologies. It deliberately excludes conversion routes that do not preserve molecular integrity (e.g., pyrolysis, gasification, fermentation, or other processes that transform native scaffolds). To promote clarity and comparability, the discussion is organised by product application into six categories: (1) pigments and natural colourants; (2) flavours & fragrances; (3) pharmacologically relevant metabolites; (4) lipophilic bioactive compounds; (5) natural antioxidants and phenolic compounds; and (6) agrochemicals. This structure elucidates the distinct challenges and opportunities within each category, guiding the design of biorefinery models that efficiently integrate green extraction strategies into high-value product chains.

2 Search strategy and data sources

This review employed a structured, systematic literature search to identify, assess, and critically analyse studies on the recovery of bioactive phytochemicals from plant-based biomass waste.14 A multi-database search was conducted using Scopus, Web of Science, PubMed, and SciELO.

Search queries combined keywords and Boolean operators. Core terms included biomass waste, agricultural by-products, green extraction, sustainable purification, phytochemicals, bioactive compound recovery, deep eutectic solvents, supercritical fluid extraction, enzyme-assisted extraction, and biorefinery valorisation. To ensure temporal relevance, priority was given to publications from 2015 to 2025, while seminal earlier works were retained when necessary to provide conceptual or methodological context.

Studies were selected based on their relevance to residual plant biomass, the level of methodological detail provided, and their potential to inform discussions on selectivity, scalability, process integration, and sustainability.

Eligible records included peer-reviewed journal articles and book chapters reporting the isolation or targeted recovery of bioactive secondary metabolites from plant-derived residues. Both conventional extraction techniques and green methodologies were considered. Conventional techniques were included when they served as relevant benchmarks for evaluating the advantages and limitations of greener alternatives. Studies focusing exclusively on thermochemical conversion routes, non-plant biomass, or crude extracts without purification were excluded.

All records were imported into a reference management software, and duplicates were removed prior to screening. Titles and abstracts were evaluated against predefined inclusion criteria, followed by full-text assessment of potentially relevant studies. The literature screening and selection process was conducted by the authors, with particular emphasis on methodological transparency, relevance to residual plant biomass, and applicability to sustainable extraction and purification schemes. Data were extracted using a standardised form that captured biomass source and yield, extraction method, and key parameters. To minimise omissions, backward citation tracking of all included studies was also conducted to identify additional relevant publications.

3 Selected phytochemicals from biomass waste

Biomass contains both primary and secondary metabolites; the latter, due to their bioactivity and broad industrial relevance, are key targets in modern biorefineries. Current efforts progress along two complementary avenues: (I) developing profitable and sustainable methods for extracting and purifying high-value compounds; (II) sourcing these bioactive compounds from non-edible feedstocks, particularly agro-industrial residues. Below, we describe selected examples of naturally occurring products whose isolation is of interest due to their biological and industrial properties.

3.1 Pigments and natural colourants

Dyes are essential compounds widely used in industries such as textiles, printing, cosmetics, and food, to provide colour to different materials. Chemically, they are chromophoric substances that interact with substrates, absorbing characteristic wavelengths of light and resulting in visible colour. Most dyes contain conjugated π-electron systems that determine their light absorption properties and the hues they produce.

Natural dyes, obtained from renewable plant, animal, or marine sources, are gaining renewed importance as sustainable alternatives to synthetic dyes. They are biodegradable, non-toxic, and typically require minimal chemical processing, which reduces pollution and health risks. Compounds such as anthocyanins and flavonoids, together with carotenoids and chlorophylls, not only provide a wide range of natural colours but also exhibit antioxidant and antimicrobial activities, arising from their distinct chemical structures. Although their current applications are still limited, primarily in the food industry and, to a lesser extent, in textiles and coatings, ongoing research and innovation are expanding their potential, positioning natural dyes as key components in the transition toward a more sustainable and environmentally conscious industry.15 Next, we present selected natural dyes and the extraction methods used to obtain them, highlighting their scalability and applications.

3.1.1 Lycopene. Lycopene 1 (Scheme 1), the red carotenoid responsible for the characteristic colour of tomatoes, is one of the most abundant dietary carotenoids and exhibits outstanding antioxidant activity, making it relevant to food preservation, functional foods, cosmetics, and pharmaceutical applications.16
image file: d5su00695c-s1.tif
Scheme 1 Chemical structures of lycopene 1 and other carotenoids.

Table 1 compares selected green extraction technologies relevant to lycopene 1 recovery from tomato-processing residues, highlighting key conditions, yields/purity, and the main advantages and limitations.

Table 1 Comparison of selected green extraction technologies relevant to lycopene 1 recovery from tomato-processing residues
Entry Biomass Scale Methodology Optimal conditions Recovery (%) Purity (%) Key findings Ref.
a FFD: full factorial design.b MAE: microwave-assisted extraction.c PAE: pulsed electric field-assisted extraction.d MUAE: low-temperature microwave-ultrasound-assisted extraction.e UPAE: electric field (PEF) and power ultrasound (US).f ROO: refined olive oil.g Supercritical CO2 (ScCO2).h RSLDE: rapid solid–liquid dynamic extraction.i SPE: solid phase extraction.
1 Tomato pulp waste without seeds 1 g Maceration extraction optimised via FFDa 20 °C, 40 min; solvent: 25% acetone in nHex (v/v); solvent volume: 40 mL 94.7 98.3 Simple & scalable. High-purity all-trans lycopene. Minimises isomerisation and degradation 17a
2 Non-pretreated tomato peels 1–50 g Maceration. Mixture design optimisation. Ternary solvents 40 °C, 30 min, optimised solvent %: 30.6 nHex, 32.8 EtOH, 36.6 acetone >95   Tomato oleoresin with 13% (w/w) lycopene 17c
Strong antioxidant capacity (1582 µmol TE per g)
3 Tomato skin Lab UAE, MAE,b PAE,c and combined MUAEd/UPAEe using green solvent (EtOH[thin space (1/6-em)]:[thin space (1/6-em)]AcOEt 2[thin space (1/6-em)]:[thin space (1/6-em)]3 v/v)   UPAE: 3.56% (highest); MUAE: 3.49%   UPAE showed the highest extraction efficiency and antioxidant activity 18b
4 Tomato peel Lab Maceration in ROOf optimised by Box–Behnken design 80 °C, 400 rpm, 45 min, 2.5% w/v peel: ROO ratio 99.3%   Enhances the oxidative stability and nutritional properties of ROO 19
5 Tomato peel Lab Enzymatic pretreatment + UAE, using nHex UAE: 15 min, 25–45 °C, after 180 min enzymatic treatment 1018–1120 mg per kg extract   Enzymatic hydrolysis enhanced lycopene release, UAE increased lycopene extraction 20
6 Tomato paste 60 g ScCO2,g factorial design; effect of T, P, flow rate, EtOH cosolvent 55 °C, 300 bar, 2 h, 4 kg per h CO2 flow, 5% EtOH 53.9   Milling improves extraction; higher temperature and pressure raise yields but risk degradation 22a
7 Tomato peel + seed (37[thin space (1/6-em)]:[thin space (1/6-em)]63 w/w) 4 g ScCO2, evaluation of temperature, pressure, flow rate, and seeds' role 90 °C, 40 MPa, 180 min, 2–4 mL per min CO2 56% (vs. 18% without seeds)   Seed oil enhanced lycopene extraction efficiency. Some losses occurred 24a
8 Tomato skin 100 g RSLDEh with naviglio extractor; pressure/depressurisation cycles; comparison with conventional solvent extraction ≈10 h, 60 pressure cycles; water as extraction fluid; SPEi purification with MeOH/acetone   >98% Water enables fast, gentle extraction, yielding high-purity lycopene for nutraceutical use 31b


Traditionally, lycopene 1 has been extracted from tomato-processing waste using organic solvents such as n-hexane (nHex), acetone, and ethyl acetate (AcOEt), achieving high purities (94–98%).17 However, environmental and safety concerns associated with volatile organic solvents have driven a transition toward greener extraction strategies.

As solvent-lean alternatives, recent studies have explored ultrasound-assisted extraction (UAE), either alone or combined with other emerging intensification tools such as microwave irradiation and pulsed electric fields, in conjunction with green media such as natural deep eutectic solvents (NADES).18

Edible oils, such as olive or sunflower oil, provide a food-grade medium that can both solubilise lycopene and enhance the oxidative stability of the extract. Olive oil maceration has achieved up to 99.3% recovery under optimised conditions (80 °C; 2.5% w/w biomass-to-oil), yielding 35 mg of lycopene 1 per kg of oil.19 UAE enhances mass transfer, resulting in a recovery rate of approximately 87% using sunflower oil as solvent.20 Nevertheless, oil type and processing intensity critically affect carotenoid stability. For example, high-intensity ultrasound can degrade labile constituents; hence, milder green conditions are recommended.21

Complementary to edible-oil maceration and UAE, ScCO2 offers an environmentally friendly route to recover lycopene 1 from tomato by-products, typically affording high pigment purity. Extraction performance is governed by pressure–temperature coupling (higher values generally increase recovery), whereas temperatures >80 °C risk thermal degradation.22 A major bottleneck is mass-transfer resistance across the chromoplast–cell-wall matrix; pretreatments such as milling or enzymatic hydrolysis mitigate this barrier and improve release.23 Co-solvents (e.g., EtOHl, vegetable oils) broaden solvating power and can markedly increase recoveries.24 Mechanistically, Squillace et al. quantified lycopene 1 solubility in tomato seed oil (ca. 460 µg g−1) and showed preferential solubility for Z-isomers, thereby supporting the use of oil co-solvents to enhance mass transfer and overall yields.25

Addressing these matrix barriers directly, enzyme-assisted extraction depolymerises pectic and cellulosic structures, thereby enhancing lycopene 1 release. Since the mid-2000s, converging evidence has shown that pectinase-based preparations, particularly those containing polygalacturonase (PG) and pectin lyase (PL), are more effective than cellulase (CL) alone for extracting lycopene 1 from tomatoes; when pectinases and cellulase are applied together, their complementary action on the pectic matrix and the cellulose–hemicellulose network synergistically disrupts cell walls and facilitates chromoplast release.26 Building on this principle, enzyme-assisted workflows that couple PG/PL/CL pretreatment followed by solvent extraction deliver lycopene-rich oleoresins, and optimisation further enhances phenolic content and antioxidant capacity.27

Moving toward greener alternatives, Cuccolini et al. developed a solvent-free process based on pH shifting and enzyme-assisted cell lysis. Using Prolyve 1000®, a protease derived from Bacillus licheniformis, they achieved up to 10% lycopene (w/w, dry basis), a 30-fold increase over untreated peels.28 This approach was later optimised by Lombardelli et al., who tailored the enzymatic blend—PG and PL (26%), CL (57%), and xylanase (XL, 17%)—to the cell-wall composition of ripe tomatoes, further improving extraction efficiency.26 In parallel, process intensification via ultrasound can act synergistically with enzymatic hydrolysis. Ladole et al. co-immobilised pectinase and cellulase on amino-functionalized magnetic nanoparticles and observed a ca 30% increase in lycopene yield from non-pretreated tomato peels when ultrasound and enzymes were applied simultaneously.29 Consistent with this, a recent optimisation of cellulase, pectinase, ultrasound time, and pH achieved high recoveries under mild conditions. Scanning electron microscopy (SEM) images revealed increased porosity, and FTIR confirmed the absence of lycopene 1 degradation, supporting the combined approach's efficiency and sustainability.30

As a fully solvent-free alternative, RSLDE based on cyclic pressure gradients (e.g., Naviglio Extractor) avoids thermal stress. It eliminates the use of VOCs, affording high-purity lycopene 1 (>98% w/w) from tomato-processing waste while preserving biomass for downstream valorisation. Kinetic modelling supports the scalability of this technology, positioning RSLDE as a promising addition to the portfolio of green lycopene extraction methods.31

In conclusion, lycopene 1 extraction has shifted from solvent-heavy protocols to greener and potentially scalable routes, delivering high-purity products with a reduced environmental footprint.

3.2 Flavours and fragrances

Flavours and fragrances are essential to the sensory experience of food, beverages, and many consumer products, as they activate our chemical senses through direct interactions with specific molecules. Driven by increasing consumer demand for natural and sustainable ingredients, current research focuses on identifying and producing volatile compounds—such as esters, terpenoids, aldehydes, and alcohols—with desirable aroma and taste profiles from plant-based sources. In this context, representative compounds of high industrial interest illustrate the chemical diversity and commercial value of natural flavour and fragrance ingredients.32
3.2.1 (R)-(+)-Limonene. (R)-(+)-Limonene (8, Scheme 2), also known as D-limonene or 1-methyl-4-isopropenylcyclohex-1-ene, is a monocyclic terpene widely distributed in nature. It is particularly abundant in the essential oils (EOs) extracted from the peels of almost all citrus fruits, where it constitutes a significant component. Due to its pleasant citrus aroma and functional versatility, D-limonene 8 is among the most common and industrially significant terpenes. It is widely used in the food, cosmetics, and pharmaceutical industries. Beyond its flavour and fragrance, D-limonene 8 has been reported to have anti-inflammatory, antiviral, anticancer, and antidiabetic activities. It also serves practical roles, as it is a liquid, nonpolar solvent with a strong affinity for petroleum-based greases. This property has long made it a popular industrial cleaner and the active component in household pest-control formulations. Valued as a safer, biodegradable alternative to solvents like methyl ethyl ketone, xylene, and the now-banned chlorofluorocarbons, D-limonene 8 is also renewable.33
image file: d5su00695c-s2.tif
Scheme 2 Examples of acyclic and cyclic structures of monoterpene hydrocarbons in essential oils.

Traditionally, D-limonene 8 has been recovered from citrus residues using conventional operations, including mechanical cold pressing, water/steam-based distillation, steam explosion, and SLE with organic solvents. While simple and effective, these routes often require lengthy extraction times, high energy input, and substantial capital investment. Within this toolbox, nHex SLE has been the workhorse; yet its health and environmental drawbacks have accelerated the shift toward bio-derived solvents.34

Against this backdrop, a comparative multi-solvent study benchmarked nine green candidates against nHex, with cyclopentyl methyl ether (CPME) and 2-methyltetrahydrofuran (2-MeTHF) emerging as the top performers. Under optimised SLE conditions, CPME and 2-MeTHF afforded 1.78% and 1.37% D-limonene 8 from orange-peel waste, ∼80% and 40% higher than nHex (0.99%). Both solvents maintained performance across three reuse cycles, and their efficiencies were comparable to conventional hydrodistillation (HD) (∼2% w/w D-limonene 8), with microscopy indicating these gains were due to enhanced cell-wall disruption.35

Beyond liquid–solvent approaches, supercritical fluid extraction (SFE) has emerged as a green, high-efficiency alternative. ScCO2 combines the gas-like diffusivity of a gas with the liquid-like solvating power of a liquid, while remaining non-toxic and easily removed via depressurisation.36 Using a 65[thin space (1/6-em)]:[thin space (1/6-em)]35 D-limonene–canola oil model system under isobaric ScCO2 (10 MPa), Yasumoto et al. demonstrated that temperature alone tunes purity versus yield: at 60 °C, D-limonene purity approached ∼99%, whereas at 30 °C recovery peaked (∼95% w/w); introducing a temperature gradient further sharpened separation.37 In line with these results, SFE of Citrus limon peels produced essential oils containing 80–88% D-limonene 8, optimised at 15 MPa and 40 °C.38 Likewise, in Citrus unshiu, Safranko et al. reported D-limonene 8 as the dominant volatile, reaching 30.7% at 300 bar.39

Complementary to the innovation in extraction media, process routes have also undergone significant advancements. By coupling microwaves directly to polar molecules within the plant matrix (chiefly intracellular water), MAE generates rapid, uniform volumetric heating that ruptures glandular structures and releases target compounds into an aqueous phase for streamlined distillation. Compared to conventional heating, MAE typically shortens extraction times from hours to minutes, reduces solvent use by ∼50–80%, lowers energy demand, and often improves yield and selectivity while preserving bioactivity.40

As a representative case, a sequential microwave-assisted hydrodistillation (MAHD) was operated at a 750 g scale in two stages: (i) heating the charge to near its boiling point and (ii) distilling the oil. The resulting essential oil—dominated by D-limonene 8 (65.1 wt%), β-pinene 9 (14.5 wt%), and γ-terpinene 10 (9.7 wt%)—exhibited potent inhibition against E. coli and S. aureus. The spent matrix was then subjected to MAE, yielding a pigment fraction enriched in polyphenolics, which underscores how microwave-driven cascading not only accelerates extraction but also delivers bioactive-rich streams suitable for downstream purification and use.41

Consistent with these advantages, the work of Golmakani & Moayyedi comparing MAHD and solvent-less microwave extraction (SLME) with HD, demonstrated a reduction in extraction time from 120 min (HD) to just 15 min (MAHD, SLME) while maintaining comparable physical and chemical properties of the essential oils obtained from Citrus limon peel. Moreover, D-limonene 8 remained the major monoterpene across methods (HD: 65.1%, MAHD: 72.3%, SLME: 68.2%), confirming that green extraction–intensification strategies do not compromise the integrity of the target compound.42 In line with these observations, Attard et al. further highlight MAE as a selective, rapid method for D-limonene 8 recovery from orange peels, reporting—under comparable setups—substantially higher yields (up to two-fold versus conventional heating), likely due to favourable microwave–matrix interactions that promote concurrent cell rupture and diffusion.43 Building on this comparative evidence, a solvent-free MAE process optimised via response surface methodology identified microwave power as the principal driver of performance and enabled rapid oil recovery without added water or organic solvents; under 1000 W for 10 min, fresh orange and lemon peels afforded 3.7% and 2.0% oil, respectively, with compositions dominated by β-myrcene 7 and D-limonene 8 (orange: 45% β-myrcene 7, 29% D-limonene 8; lemon: 19% β-myrcene 7, 15% D-limonene 8).44

This improved performance is not limited to citrus peel. A recent study on Citrus limon leaves demonstrated that SLME can also provide bioactive-rich essential oils, yielding 2.5% oil after 50 minutes at 110 °C and 300 W, with D-limonene 8 (34.1%) as the dominant component.45 These extracts showed strong antioxidant activity and exhibited potent antimicrobial effects, supporting their application in food, cosmetic, and pharmaceutical formulations.

At the process scale, considerations such as feedstock viscosity and reactor configuration for a citrus biorefinery were addressed, identifying optimal MAHD conditions: 20 minutes at a solid-to-water ratio of 1[thin space (1/6-em)]:[thin space (1/6-em)]1.5 and constant pressure of 300 mbar. Under these conditions, orange peel afforded 1.8% (dry basis)—comparable to HD (1.7%; dry basis)—with no remarkable compositional differences; D-limonene 8 remained predominant (96.8% for HD; 97.4% for MAHD).46

Complementing these solvent-free, energy-efficient strategies, UAE offers a low-temperature acoustic route for recovering bioactive compounds. Ultrasound (>25 kHz) generates acoustic cavitation—microscopic bubbles that form and collapse—producing localised shear and microjets that rupture cell walls. This micro-disruption improves solvent penetration and mass transfer, accelerating the release of intracellular compounds while minimising reliance on organic solvents. The gains stem from the combined effects of cell fragmentation and enhanced diffusion, positioning UAE as a strong candidate for the sustainable extraction of citrus-derived D-limonene 8.47

In a recent study on D-limonene 8 recovery from sweet lime (Citrus limetta) peel, UAE reduced the total extraction time to 15–20 min compared with ∼185 min for the conventional process. Under optimised conditions, UAE yielded 3.29 g D-limonene 8 per 100 g peel (∼97% of the essential oil), and SEM imaging confirmed ultrasound-induced disruption of cells and particles.48

Extending this concept, concomitant ultrasound–microwave irradiation (UMAE) couples cavitation-driven cell disruption with rapid volumetric heating, offering additive or synergistic benefits from the laboratory to industrial scales.49 Although evidence remains limited, González-Rivera et al. showed that UMAE produced 1.53% (w/w) essential oil from fresh orange peel in 60 min, matching HD (1.55) in less than half the time and saving >60% energy; D-limonene 8 dominated (∼95%), underscoring UMAE's promise and the need to define optimal operating windows.50

In summary, citrus processing residues constitute a valuable renewable source of D-limonene 8 when combined with efficient extraction and process-intensification strategies. The adoption of green solvents and energy-efficient technologies enables high recovery while reducing processing time, solvent use, and environmental impact, reinforcing D-limonene 8 as a high-value terpene for sustainable industrial applications.

3.3 Pharmacologically relevant metabolites

For millennia, medicinal and aromatic plants have underpinned healthcare, with ethnopharmacological knowledge first passed down orally and later codified in pharmacopoeias. As traditional remedies evolved into modern pharmacology, the isolation of active principles—such as morphine, digitoxin, and quinine—marked a turning point. Since then, many essential medicines have been derived from nature. Their enduring value reflects the exceptional structural diversity and evolutionary “fine-tuning” of natural products, which makes them potent modulators of complex biological pathways, especially in cancer and infectious diseases.51

Recent advances align closely with a circular-bioeconomy vision, in which agro-industrial residues are converted into standardised, renewable sources of bioactive compounds for therapeutic development. By applying green, intensified extraction routes (e.g., MAE, UAE, SFE), producers can secure a sustainable supply while preserving molecular integrity—positioning biowaste as a high-value pharmaceutical feedstock for the next generation of natural medicines.52

3.3.1 Artemisinic acid and artemisinin. Amid rising resistance in Plasmodium falciparum, the WHO recommends artemisinin-based combination therapies as the standard of care for uncomplicated malaria. In 2021, WHO reported 241 million cases globally and at least 627[thin space (1/6-em)]000 deaths.53

Artemisinin 10, the key active pharmaceutical ingredient, is naturally produced in low yields (0.4%) from the plant Artemisia annua, making it insufficient to supply the over 300 million treatments required annually. To address this limitation, a scalable process has been developed in which dihydroartemisinic acid 12—an inactive biological precursor—is photochemically oxidised with singlet oxygen (Scheme 3). This one-pot, continuous-flow process yields artemisinin 10 in 65% yield, producing batches of up to 365 kg from 600 kg of precursor, with an overall yield of 55%.54


image file: d5su00695c-s3.tif
Scheme 3 Obtention of artemisinin 10 from natural sources and semi-synthetic processes.

To ensure a more sustainable supply chain, artemisinic acid 11 can be efficiently biosynthesised using metabolic engineering.55 Additionally, dihydroartemisinic acid 12 of high purity (up to 98 wt%) can be recovered from Artemisinin Production Waste (APW)—an oily byproduct of A. annua extraction—through a purification strategy combining anion-exchange resin and silica gel column chromatography. Dihydroartemisinic acid 12 is first captured on an anion-exchange resin by exploiting its carboxylate. Of ten candidates, the styrene–divinylbenzene 717 resin showed the highest capacity and was selected for optimisation. Efficient desorption is achieved with 10% NH4Cl in 80% EtOH. The enriched fraction is then polished by silica-gel chromatography (nHex/AcOEt, 0–20%) followed by recrystallisation to remove oils and pigments. This sequence routinely affords ≥98%-pure dihydroartemisinic acid 12 with >80% overall recovery and has been validated at 10× scale, supporting industrial applicability56

Given the limitations of natural extraction, these innovations in synthetic biology and process engineering offer scalable, environmentally friendly alternatives for artemisinin 10 production. Together, these advances represent a promising approach for increasing the supply of antimalarial treatments.

3.3.2 Plant-derived cannabinoids: cannabidiol 13 (CBD). Cannabinoids are a diverse group of bioactive compounds that interact with the human endocannabinoid system, producing distinct pharmacological effects. Their actions range from psychoactive and analgesic to anti-inflammatory and neuroprotective, making them an expanding focus of scientific and medical research and promising candidates for alleviating various human ailments. More than 100 phytocannabinoids have been identified, among which cannabidiol (CBD, 13) and Δ9-tetrahydrocannabinol (Δ9-THC, 15) are the most extensively studied (Scheme 4). Of particular interest is CBD 13, a non-psychoactive compound with therapeutic potential for numerous neurological and psychiatric disorders, including Parkinson's, Alzheimer's, anxiety, and depression.57 Sativex®, an oromucosal spray containing an equimolar combination of CBD 13 and THC 15 (2.7 mg THC/2.5 mg CBD per spray), is the first phytocannabinoid-based medicine and has been approved in several countries for the treatment of neuropathic pain associated with multiple sclerosis.58
image file: d5su00695c-s4.tif
Scheme 4 Structures of the major cannabinoids.

Cannabinoids occur chiefly in cannabis, a genus of the Cannabaceae family, where Cannabis sativa includes three morphological varieties: sativa, indica, and ruderalis.59 Although hemp and marijuana belong to the same species (C. sativa), they arise from distinct cultivars with different chemotypes, uses, and legal status. Drug-type cannabis has a high Δ9-THC[thin space (1/6-em)]:[thin space (1/6-em)]CBD ratio (typically ∼5–30% Δ9-THC), producing psychoactive effects, whereas fiber-type cannabis (hemp) shows the opposite profile: very low Δ9-THC 15 and relatively higher CBD 13, lending itself to textiles, foods, cosmetics, and wellness products.60 In many jurisdictions, “hemp” is now a legal term rather than a botanical one, referring to cannabis that contains no more than a defined THC 15 threshold (often ≤0.3%).61

This review centers on the by-products of hemp cultivation and processing. Hemp has been valued for millennia for its medicinal and industrial uses and is now legally cultivated worldwide as a highly versatile crop. It is grown for multiple components—fibers, seeds, leaves, and flowers—each with distinct applications: bast fibers prized for strength and durability in paper, textiles, automotive parts, and bio-based construction, and flowers rich in cannabinoids and terpenes with well-documented therapeutic potential.62

As demand for hemp-based products rises, processing for fiber and seed production generates substantial residues, including hurds, leaves, and inflorescences, with up to 33% of the plant mass lost as dust during fiber separation. Often considered low-value waste due to their complex composition, rich in waxes and cannabinoids, these by-products remain underutilised despite their potential for the recovery of bio-based compounds of economic interest.63

Although CBD 13 is not present in its active form in raw industrial hemp, it can be obtained by decarboxylating its precursor, cannabidiolic acid (CBDA) 14, a process typically induced by heat or light. Kinetic studies indicate pseudo-first-order behaviour with optimal conversion at 140 °C for ∼30 min, followed by product degradation, and a direct β-keto-acid mechanism whose rate depends on time, temperature, and matrix composition.64 Fiorini et al. emphasise that proper pretreatment, particularly the decarboxylation of dry hemp inflorescences immediately before HD, is essential to obtaining CBD-rich essential oil. In contrast, steam distillation of fresh material yields low CBD 13 content.65 These findings highlight the critical role of processing parameters in maximising the industrial value of hemp-derived products.

Among various extraction techniques, several patents describe the use of ScCO2 to recover CBD 13 from industrial hemp waste, typically followed by purification steps including decarboxylation, distillation, flash chromatography, and crystallisation. For example, Eiroa Martínez et al. detail the extraction of CBD 13 from hemp waste pellets at 60 °C and 300 bar, yielding a crude resin containing 20% of the phytocannabinoid 13. Despite the relatively low concentration compared to solvent-based extractions, high-purity CBD 13 isolates (up to 99.8%) can be obtained following appropriate downstream processing.66 Similarly, Pertile and Black describe extracting oil under milder conditions (35 °C, 127 bar), followed by decarboxylation and purification using nonpolar solvents.67

Marzorati et al. investigated a downstream processing strategy to obtain CBD-enriched products from hemp inflorescences.68 In their study, conventional MeOH-based recovery was compared with ScCO2 processing. While MeOH consistently afforded higher overall mass yields, ScCO2 produced fractions with markedly higher CBD 13 concentrations, as summarised in Table 2, reflecting its superior selectivity. A pre-treatment of dried biomass at 100 °C for 6 h prior to processing enhanced CBD 13 yields by promoting CBDA 14 decarboxylation (entries 3–4). This approach generated a crude oil containing approximately 50 wt% CBD 13. Subsequent purification via winterisation and flash chromatography on Celite® effectively removed waxes and Δ9-THC 15, affording a final product with nearly 80 wt% CBD 13 purity (entry 5).

Table 2 Extraction performance (MeOH vs. ScCO2) and cannabinoid contents (CBD 13, Δ9-THC 15) across purification stages, as reported by Marzorati et al.68
  Methodology Extraction (%) CBD (wt%) Δ9-THC (wt%)
a n.d.: not detected.
1 Sample[thin space (1/6-em)]:[thin space (1/6-em)]MeOH (ratio 1[thin space (1/6-em)]:[thin space (1/6-em)]10, w/w), 2 h, r.t 22 3.0 ± 0.5
2 ScCO2 (380 bar, 60–80 °C) 14 15.8 ± 0.3
3 (1) 100 °C for 6h 17 45.2 ± 0.2
(2) MeOH extraction
4 (1) 100 °C for 6h 13 50.2 ± 0.2 3.01 ± 0.01
(2) ScCO2 extraction
5 (1) 100 °C for 6h   79.0 ± 0.4 n.da
(2) ScCO2 extraction, 60 °C and 380 bar
(3) Winterisation with EtOH
(4) Flash chromatography, adsorption on celite


In contrast, Calmanti et al. adopted a more refined and environmentally conscious strategy from industrial hemp, incorporating mild decarboxylation (80 °C, 24 h), ScCO2 extraction under gentler conditions (40 °C, 250 bar), selective winterisation with acetonitrile, followed by C18 reversed-phase filtration, silica gel chromatography, and final crystallisation to obtain CBD 13 with a purity exceeding 99% and an overall yield of 52%.69 This multistep approach not only enabled the isolation of crystalline CBD 13 with pharmaceutical-grade purity but also prioritised solvent recovery and minimised product losses throughout the process. Overall, the Calmanti et al. protocol demonstrates superior selectivity, scalability, and sustainability, making it a more suitable option for industrial-scale production of high-purity CBD 13.

Although ScCO2 extraction is a promising and environmentally friendly route for valorising industrial hemp waste, complementary approaches have been explored to further enhance process efficiency and applicability. Among these, pressurised liquid extraction (PLE) combined with thermochemical decarboxylation has proven highly effective for isolating CBD 13 from leaves, seeds, stalks, and small inflorescences. In this approach, acidic cannabinoids are thermally converted to their neutral forms using water as the PLE medium (140 °C, 11.0 MPa, two 3-min static cycles). Despite the poor aqueous solubility of cannabinoids, water is intentionally used as the reaction medium, yielding a 99.2% conversion of CBDA 15 to CBD 13. The thermally treated biomass is then extracted with EtOH to give a CBD-rich extract (75.8% purity), and subsequent C18 reversed-phase chromatography followed by crystallisation affords CBD 13 at 91.8% purity.70

In summary, these studies demonstrate that the recovery of CBD 13 from industrial hemp by-products is strongly influenced by the interplay among biomass pretreatment, extraction strategy, and downstream purification. While ScCO2 enables high selectivity and access to pharmaceutical-grade CBD 13 through carefully designed multistep protocols, alternative approaches such as PLE combined with controlled decarboxylation offer efficient and versatile routes for converting diverse hemp residues into CBD-rich products. Collectively, these findings highlight the substantial potential of hemp processing residues as renewable feedstocks for the sustainable production of high-value cannabinoids and underscore the importance of process optimisation in maximising their industrial valorisation.

3.4 Lipophilic bioactive compounds

Lipophilic bioactive compounds constitute a particularly valuable fraction of plant-derived phytochemicals recovered from biomass waste. Beyond the well-known polar constituents, many agro-industrial residues are enriched in a diverse unsaponifiable fraction that includes pentacyclic triterpenes, phytosterols, and tocopherols. These molecules share key features, including hydrophobic character, low volatility, and high chemical stability. At the same time, they display a range of biological and functional properties—including antioxidant and anti-inflammatory activities as well as cholesterol-lowering and membrane-stabilising effects—that make them relevant to food, cosmetic, nutraceutical, and pharmaceutical formulations. Consequently, the selective recovery of these lipophilic compounds from residual biomass aligns well with circular bioeconomy strategies, adding value to waste streams while reducing dependence on conventional raw materials.71

Within this group, pentacyclic triterpene acids such as oleanolic 21 (OA), maslinic 22 (MA) and ursolic 23 (UA) acids typically coexist with phytosterols and tocopherols in the same matrices, making them attractive targets for integrated recovery schemes. In the following sections, we discuss representative examples of these compounds and highlight their occurrence in biomass.

3.4.1 Pentacyclic triterpene acids (OA, MA, UA). Triterpenes constitute a broad and structurally diverse class of natural metabolites biosynthesised via cyclisation of the C30 precursor squalene 26. Central to this pathway are 2,3-oxidosqualene cyclases, key enzymes that convert 2,3-oxidosqualene into a wide array of cyclic triterpenes and sterols. These metabolites are widely distributed in nature and display a broad spectrum of pharmacological activities. Structurally, triterpenoids are generally divided into tetracyclic and pentacyclic families, the latter of which—particularly pentacyclic triterpene acids (PTAs)—has attracted increasing scientific and industrial interest. While the lupane, oleanane, and ursane scaffolds are the most extensively investigated, other frameworks, such as hopane, taraxastane, and friedelane, have also emerged as promising bioactive architectures (Scheme 5). Their therapeutic potential is supported by experimental and clinical evidence demonstrating anti-inflammatory, anticancer, antimicrobial, neuroprotective, and metabolism-modulating effects. Several PTAs have already progressed into clinical use, especially in the management of liver disorders and type 2 diabetes.72
image file: d5su00695c-s5.tif
Scheme 5 Classification of pentacyclic triterpenes into the lupane, oleanane, and ursane groups, shown together with squalene as their common structural precursor.

Among natural sources, Olea europaea (olive tree) stands out not only for its cultural and nutritional significance within the Mediterranean diet, but also for its remarkable abundance of PTAs. However, olive processing generates vast quantities of by-products—estimated at 30 million cubic meters annually—representing an environmental burden and an economic challenge for producers.73

OA 21 and MA 22 exemplify the intrinsic difficulties in isolating structurally similar PTAs, as their close resemblance necessitates highly selective purification methods. For instance, flash chromatography on silica gel using nHex/AcOEt (79[thin space (1/6-em)]:[thin space (1/6-em)]21) affords up to 10.9 mg g−1 of OA 21, whereas an AcOEt/AcOH (92[thin space (1/6-em)]:[thin space (1/6-em)]8) system yields 6.25 mg g−1 of MA 22.74 Although these values surpass earlier reports, they still rely on solvent-intensive, non-sustainable chromatographic conditions.

Recent studies focused on valorising olive-derived residues reveal strong matrix-dependent behaviour. Velasco et al. demonstrated that PTAs preferentially partition into lipophilic fractions of crude olive pomace oil, which contained markedly higher concentrations (2.5–48.4 g kg−1) than corresponding semisolid matrices (1.2–3.0 g kg−1). Moreover, the dominant triterpene shifted with matrix composition—OA 21 dominated semisolid forms, while MA 22 was more abundant in oil fractions—highlighting the need for matrix-tailored extraction strategies.75

In parallel, greener separation platforms have gained traction as alternatives to traditional solvent-intensive workflows. A notable example of SFE with pH-zone refining centrifugal partition chromatography (CPC) is the use of ScCO2 with EtOH as a cosolvent, which enables efficient recovery of triterpenoids. Subsequent CPC using MtBE/acetonitrile/water (4[thin space (1/6-em)]:[thin space (1/6-em)]1[thin space (1/6-em)]:[thin space (1/6-em)]5) affords baseline separation of OA 21 and MA 22 with purities of 94–97% and recoveries above 95%.76

Beyond these compositional effects, recent biorefinery-oriented workflows have demonstrated that pretreatment steps can significantly impact subsequent PTAs recovery. A representative case is the MAE using water as the solvent for olive pomace, initially optimised using response surface methodology to maximise the solubilisation of polar constituents.77 Under the selected conditions (100 °C, 16 min, 12% w/v), this process yields two complementary streams: (i) an aqueous extract enriched in hydrophilic compounds and (ii) a structurally modified solid residue enriched in PTAs. The treated solid then constitutes an advantageous substrate for a second extraction stage. EtOH maceration of this residue affords substantially higher levels of OA 21 and MA 22—3.60 and 9.54 mg g−1 extracted solid, respectively—than those obtained from the untreated biomass. This enhancement is attributed to MAE-induced tissue disruption and to the increased proportion of lipophilic extractives in the residual solid, which together facilitate the release of triterpenoids.

Complementary insights arise from a comparative evaluation of UAE, MAE, and conventional solvent extraction for the recovery of OA 21 and MA 22 from olive pomace. Xie et al. demonstrated that UAE yields the highest extraction efficiencies, driven by intense acoustic cavitation, faster mass transfer, and more favourable kinetic and thermodynamic parameters.78 Under optimal UAE conditions, OA 21 and MA 22 concentrations reached 29.8 and 381.2 mg g−1, outperforming both MAE and solvent extraction. Notably, SEM analyses revealed extensive cell-wall rupture under UAE, far exceeding the structural damage caused by MAE or solvent extraction, thereby explaining the superior release of intracellular triterpenes. In addition to offering higher yields and significantly shorter extraction times, UAE also showed the lowest E-factor, energy consumption, and carbon emissions, establishing it as the greenest and most effective technique for PTAs and phenolic recovery from olive pomace.

Extending beyond olive-derived matrices, Eucalyptus species offer another underutilised source of PTAs, particularly within the pulp and paper industry, which generates substantial lignocellulosic waste (approx. 0.27 tons per ton of cellulose).79 Oliveira et al. proposed an integrated biorefinery strategy for Eucalyptus globulus leaves, wherein essential oils (EOs) are first obtained via HD. The residual biomass is then subjected to PTAs extraction using the same EOs, rich in 1,8-cineole, as a bio-based solvent. The comparable extraction efficiencies of whole EOs (2.8% dw) and pure 1,8-cineole (2.7% dw) validate the effectiveness of this solvent recycling strategy. Both solvents achieved high recoveries of OA 21 (6.0 and 5.7 g per kg dry weight) and UA 23 (18.3 and 17.9 g per kg dry weight), demonstrating the viability of solvent-saving, circular-integrated protocols (Fig. 1).80


image file: d5su00695c-f1.tif
Fig. 1 Integrated biorefinery for the recovery of EOs and PTAs from Eucalyptus globulus leaves.

Complementary to EO-based systems, another promising alternative is the use of Deep Eutectic Solvents (DESs)—particularly Natural Deep Eutectic Solvents (NADESs) composed of primary metabolites such as organic acids, amino acids, or sugars—which offer low volatility, tuneable polarity, and high solubilization capacity, while remaining biodegradable and non-toxic.81

Silva et al. evaluated green extraction strategies using NADESs and showed that a menthol[thin space (1/6-em)]:[thin space (1/6-em)]thymol (1[thin space (1/6-em)]:[thin space (1/6-em)]2) eutectic mixture at room temperature outperformed conventional methods, including ScCO2 and soxhlet extraction. Yields of 0.84 wt% OA 21 and 1.8 wt% UA 23 from Eucalyptus globulus bark illustrate both the efficiency and the environmental benefits of DES-based extraction.82 The synergistic use of DESs with ultrasound has also emerged as a powerful strategy. In Eriobotrya japonica leaves, a thymol: benzyl alcohol DESs (2[thin space (1/6-em)]:[thin space (1/6-em)]1 molar ratio) under mild conditions (60 °C, 60 min, 1[thin space (1/6-em)]:[thin space (1/6-em)]10 solid-to-solvent ratio) produced a crude extract containing 81.2% PTAs—mainly OA 21, MA 22, UA 23 and corosolic acid (CA) 24. Subsequent purification yielded UA 23 and CA 24 at purities of 93.9% and 69.3%, respectively. Meanwhile, solvent recovery via low-pressure C18 reversed-phase chromatography ensured consistent extraction efficiency across multiple reuse cycles.83

Hydrophobic DESs derived from menthol have also shown a remarkable capacity to enhance the solubility of UA 23. A 1[thin space (1/6-em)]:[thin space (1/6-em)]1 menthol[thin space (1/6-em)]:[thin space (1/6-em)]thymol eutectic system increased its solubility by almost an order of magnitude relative to EtOH (36.2 vs. 4.16 µg mL−1) in apple-peel extraction.84

Other green solvents have been proposed for PTAs recovery from non-olive residues. Dimethyl carbonate (DMC)—a biodegradable, low-toxicity solvent—has been used for the selective extraction of OA 21 from grape pomace, delivering the highest molar selectivity (61%) among the solvents tested (n-BuOH, acetone, AcOEt and 2-MeTHF) and maintaining its efficiency over three reuse cycles.85 In addition, ionic liquids (ILs) have been explored as alternative media for PTA extraction. Although pure PTAs were not isolated, de Faria et al. assessed aqueous ILs solutions as hydrotropes or surfactants to enhance PTAs solubility. Hydrotropic systems afforded only modest gains, whereas surfactant-type ILs, particularly 1-tetradecyl-3-methylimidazolium chloride at 500 mM and 80 °C, delivered markedly improved recoveries. From green apple peels, this approach afforded 2.62 wt% PTAs, outperforming chloroform (2.48 wt%) and acetone (1.37 wt%) under comparable extraction conditions.86

Overall, recent advances show that matrix-tailored pretreatments and green, intensified extraction strategies enable the efficient and sustainable recovery of high-PTAs from agro-industrial residues, reinforcing their potential within integrated biorefinery frameworks.

3.4.2 Phytosterols and tocopherols. Tocopherols, the vitamin E homologues (α-, β-, γ- and δ-tocopherols), and phytosterols—particularly β-sitosterol—(Scheme 6) represent two major families of lipophilic phytochemicals that have attracted considerable attention due to their well-documented health benefits.
image file: d5su00695c-s6.tif
Scheme 6 Chemical structures of selected phytosterols and tocopherols.

Biosynthetically and structurally related to triterpenes, phytosterols are plant-derived sterols that are structurally analogous to cholesterol but differ in side-chain substitutions and ring saturation patterns. Because of this structural similarity, they competitively inhibit intestinal cholesterol absorption, thereby reducing plasma low-density lipoprotein (LDL) cholesterol levels. In addition to their cholesterol-lowering properties, phytosterols exhibit anti-inflammatory and anticancer activities. Long-term consumption of phytosterol-rich foods has been associated with a reduced risk of cancer, as well as the prevention of cardiovascular and cerebrovascular diseases. As humans cannot synthesise phytosterols endogenously, dietary sources such as vegetable oils, nuts, and mushrooms are essential, providing mainly β-sitosterol 31, campesterol 32, and soya sterols.87

Tocopherols 27–30 act as potent lipid-soluble antioxidants and are involved in key physiological processes, including membrane stabilisation, immune modulation, and the prevention of oxidative damage.88

Together, phytosterols and tocopherols are widely recognised as bioactive components of high nutritional and functional value. Their co-occurrence in the unsaponifiable fraction of many plant oils and agro-industrial residues, combined with their similar hydrophobic character, makes them attractive targets for integrated and sustainable recovery strategies within circular biorefinery frameworks.

One of the most promising sources of these high-value molecules is deodoriser distillate (DD), a secondary byproduct generated during the steam deodorisation step of edible oil refining, primarily used to reduce free fatty acids (FFAs). DD is a complex mixture composed of FFAs, mono-, di-, and triglycerides, sterol esters, phytosterols, tocopherols 27–30, and squalene 26. These complex compositions pose a challenge for the efficient extraction of tocopherols 27–30 for industrial applications. Given that millions of tons of DD are discarded each year globally, valorising it through the recovery of nutraceutical and cosmeceutical ingredients offers a valuable opportunity to reduce environmental burdens.89

Several extraction and purification methodologies have been developed for DD, particularly from soybean (SODD) and rapeseed oils (RODD). Among these, ScCO2 extraction has emerged as a commercially viable technique. Recent studies based on detailed process simulations have confirmed the technical and economic viability of recovering squalene 26 from DD via an integrated strategy combining supercritical EtOH esterification, ScCO2 extraction, and purification. Olive DD showed the highest performance, yielding up to 95 g kg−1 of squalene 26 with 99% purity and surpassing other feedstocks. Additionally, valuable co-products, such as high-purity ethyl esters and tocopherol–sterol mixtures, enhance the overall process value.90 Notably, Asl et al. reported that ScCO2 extraction of saponified RODD using 5% EtOH as a cosolvent achieved three times higher efficiency than a modified Soxhlet method, yielding extracts rich in phytosterols—primarily β-sitosterol 31 (50 wt%) and campesterol 32 (36.3 wt%).91

In addition to supercritical extraction, crystallisation has proven effective for the recovery of phytosterols. Yang et al. reported a two-step protocol involving the alkaline hydrolysis of SODD, followed by crystallisation in an acetone–EtOH mixture (4[thin space (1/6-em)]:[thin space (1/6-em)]1 v/v) at a 1[thin space (1/6-em)]:[thin space (1/6-em)]2.5 (mass/mass) sample-to-solvent ratio. This process yielded a white solid containing 23.0 wt% phytosterols, initially 91.8 wt% and increasing to 97.2 wt% after three crystallisation cycles, highlighting its potential scalability and efficiency.92

Beyond being a valuable source of bioactive compounds, DD has also been explored as a versatile feedstock for the integrated production of biodiesel and the recovery of functional ingredients such as fatty acid sterol esters (FASEs). Biodiesel can be produced from DD via chemical transesterification, supercritical fluid processing, or enzymatic catalysis. Among these, enzymatic methods have gained increasing interest due to their milder reaction conditions, higher selectivity, fewer side products, and overall environmental compatibility.93

Early advances in the enzymatic valorisation of SODD were made by Shimada et al., who showed that Candida rugosa lipase selectively esterified sterols without affecting tocopherols, even in the presence of water. Their method combined distillation to concentrate tocopherols, enzymatic esterification of sterols with FFAs, and molecular distillation, allowing the recovery of a distillate with 65 wt% tocopherols and a residue enriched in FASEs, with over 95% of sterols esterified after two treatments.94

Building on this, Watanabe et al. developed a two-step enzymatic process that also included the hydrolysis of acylglycerols and methyl esterification of FFAs to FAMEs. After 40 h, 80% of sterols were converted to FASEs, acylglycerols were fully hydrolysed, and FFA content dropped by 78%. A second enzymatic treatment, after short-path distillation, further purified the products: tocopherols reached 76.4% purity (89.6% recovery) and sterols 97.2% (86.3% recovery).95 Torres et al. further refined this concept with a dual-lipase system combining C. rugosa and Novozym 435, thereby enhancing selectivity, process simplicity, and scalability without requiring water or vacuum, paving the way for efficient downstream purification via supercritical fluid extraction.96

Recently, Lv et al. developed a green method using an immobilised lipase, MAS1-H108A, coupled with molecular distillation. This system achieved a 97.8% FAME yield, enabling the recovery of a high-value heavy phase enriched in tocopherols, squalene 26, and β-sitosterol 31, with excellent enzyme reusability (Fig. 2). The integration of enzymatic catalysis and distillation, therefore, presents a compelling model for sustainable industrial-scale valorisation.97 In parallel, a complementary process-simulation strategy has been proposed to optimise tocopherol recovery from SODD by molecular distillation: a scalable computer-simulated model based on a simplified pseudo-binary mixture of α-tocopherol and glycerol trioleate predicted a tocopherol purity of 44.87% for the simplified distillate, in excellent agreement with the experimental value of 43.75% under typical molecular distillation conditions (180 °C, 2.5 Pa).98


image file: d5su00695c-f2.tif
Fig. 2 Synergically synthesising biodiesel and recovering bioactive compounds by combining an enzymatic process and molecular distillation.

Another promising methodology is SPE, which has shown great potential for the selective recovery of tocopherols and sterols. For industrial applicability, the porous materials used in SPE must be cost-effective and offer high selectivity and capacity. Zeolites, especially those modified to alter their aluminium or silicon content, have shown exceptional performance in this context.99 For instance, the KOH-modified ZSM-5 zeolite significantly outperformed both unmodified and HCl-treated versions in extracting α-tocopherol 27 and β-sitosterol 31 from sunflower oil DOD. Under optimised conditions, the recovery rates reached 99.20% for α-tocopherol 21 and 97.32% for β-sitosterol 25.100

Overall, recent advances demonstrate that DD and related agro-industrial residues are highly promising feedstocks for the integrated and sustainable recovery of phytosterols and tocopherols, with supercritical fluids, enzymatic processes, and selective separation techniques enabling high yields, purity, and scalability within biorefinery-oriented frameworks.

3.5 Natural antioxidants and phenolic compounds

Natural antioxidants constitute a broad group of non-enzymatic molecules capable of preventing or delaying the oxidation of key biomolecules—lipids, proteins, and DNA—even at very low concentrations. Their relevance spans from food preservation to human health, as they act by scavenging free radicals, chelating transition metals, and interrupting oxidative chain reactions. While endogenous antioxidants offer a first line of defense, dietary antioxidants such as polyphenols, vitamins, flavonoids, and thiol-containing compounds play a vital complementary role, mitigating oxidative stress associated with chronic diseases and protecting against nutrient degradation. Plant-derived antioxidants have gained increasing prominence due to their biocompatibility, consumer preference for natural additives, and multifunctional properties in both food and nutraceutical applications.101 Within this context, citrus flavanones, such as hesperidin, and Oleaceae secoiridoids, including oleuropein, as well as Lamiaceae polyphenols, including rosmarinic acid, and pungent alkamides and capsaicinoids, represent key antioxidant families of high industrial and biological value. Their structural diversity, abundance in agro-industrial residues, and strong radical-scavenging capacity make them essential targets for sustainable extraction, valorisation, and application across modern biorefinery and clean-label preservation strategies.
3.5.1 Abietane diterpenes and rosmarinic acid from lamiaceae. The Lamiaceae family is a prolific source of bioactive metabolites, notably the phenolic compound rosmarinic acid 35 and the abietane-type diterpenes carnosic acid 36 and carnosol 37 (Scheme 7), which are widely recognised for their strong antioxidant capacity and multifunctional bioactivity. Abietane diterpenoids, particularly abundant in genera such as Salvia and Rosmarinus, comprise a structurally diverse class associated with a broad range of pharmacological effects, including anti-inflammatory, antimicrobial, antitumour, and neuroprotective activities.102 Complementing these diterpenes, rosmarinic acid 35 acts as a signature antioxidant of rosemary and related species, with reported roles in antiviral and antibacterial defence, neuroprotection, and food preservation.103 Together, these compounds constitute key antioxidant systems within the Lamiaceae family, underscoring both the biological significance of this botanical group and its growing relevance for food, cosmetic, and health-related applications.104
image file: d5su00695c-s7.tif
Scheme 7 Structural representation of potent antioxidant metabolites from the Lamiaceae family.

Driven by increasing industrial demand, the selective isolation of rosmarinic acid 35, carnosic acid 36, and carnosol 37 has become a significant research focus, particularly for the development of sustainable and resource-efficient supply chains. In this context, rosemary-derived matrices, especially leaves and post-distillation residues, have emerged as renewable, underutilised feedstocks. These byproducts, rich in phenolic compounds, exemplify a waste-to-value strategy by enabling the recovery of high-value antioxidants while simultaneously reducing agro-industrial waste streams.105 Supporting this perspective, Chen et al. reported the isolation of novel labdane- and isopimarane-type diterpenoids with pronounced neuroprotective activity from solid residues remaining after essential oil extraction, highlighting the untapped chemical potential of rosemary byproducts.106

Despite this chemical richness, the efficient exploitation of these metabolites is constrained by their variable natural abundance. In rosemary, carnosic acid 36 content fluctuates seasonally and decreases under abiotic stress, consistent with its role as a stress-responsive antioxidant.107 To overcome supply limitations, in vitro cultures of R. officinalis have been explored as alternative production platforms, enabling controlled biosynthesis under optimised conditions.108 However, these systems often suffer from low yields and high operational costs, limiting their industrial scalability.

Traditionally, carnosic acid 36 and carnosol 37 have been extracted using organic solvents due to their poor water solubility. A representative example is the maceration of HD residues of Salvia canariensis L. in acetone, followed by alkaline treatment and purification using Sephadex® LH-20 column chromatography, affording carnosol 37 with 99% purity (by NMR) and a yield of 1.8 g per 100 g of dried extract (Scheme 8).109 Sephadex LH-20, an epichlorohydrin-crosslinked dextran gel, is widely employed for the purification of phenolics and diterpenes due to its size-exclusion and adsorption properties, and can be reused after appropriate washing. However, despite its effectiveness, chromatographic methods based on Sephadex LH-20 or other resins often deliver only moderate selectivity and rely on volatile organic solvents such as acetone or MeOH, raising environmental and safety concerns.


image file: d5su00695c-s8.tif
Scheme 8 Extraction process of carnosic acid 36 and carnosol 37 from cultivated S. canariensis.

These limitations have motivated the exploration of adsorption-based alternatives, particularly SPE approaches employing non-ionic macroporous resins, which enable phenolic recovery from aqueous matrices with reduced solvent consumption and simplified downstream processing.

Indeed, similar limitations have been reported in related systems. For instance, Kim et al. employed Sephadex LH-20 with 100% MeOH to purify rosmarinic acid 35 from Melissa officinalis extracts, obtaining the compound with a purity of only 38.8%.110 Likewise, Zhang et al. used NK-109 macroporous resin to purify rosmarinic acid 29 from Perilla seed extracts, achieving 42.1% purity, with adsorption behaviour fitting pseudo-second-order kinetics and the Langmuir model.111 These studies highlight the robustness of classical column chromatography but also its limited selectivity and efficiency when applied to complex plant matrices.

Distillation effluents from rosemary, sage, thyme, and oregano have been identified as rich sources of rosmarinic acid 35 and related phenolics, which can be efficiently concentrated and partially fractionated via dynamic or static adsorption–desorption with macroporous resins, particularly XAD-7.112 Optimized SPE-based methodologies yield fractions with increased total phenolic content and enhanced antioxidant and hypoglycaemic activities, while offering practical advantages over conventional extraction approaches, including lower reagent consumption, reduced operational costs, simplified handling, and scalability.

In parallel, alternative green extraction methods, such as hydrotropic extraction, have emerged as promising approaches for the recovery of poorly water-soluble phytochemicals. Hydrotropes are small amphiphilic molecules capable of markedly enhancing aqueous solubility through noncovalent interactions—such as π–π stacking and dipole–dipole interactions—without micelle formation. This mechanism can increase solubility by up to 200-fold while simultaneously promoting cell wall disruption.113 Hydrotropic extractions typically involve maceration in a hydrotropic solution, followed by dilution below the minimal hydrotropic concentration to induce target compound precipitation and subsequent filtration.114

The Nardello-Rataj group demonstrated the effectiveness of this approach using alkyl polyglycosides and polyethylene glycol derivatives, with isoamyl xyloside showing superior selectivity for carnosic acid 36 over UA 23 under mild conditions (30% hydrotrope, 25 °C), achieving 23.3% carnosic acid 36 content.115 Further studies reported yields of carnosic acid 36, ranging from 1.02–1.21 g L−1, highlighting the potential of hydrotropic systems for low-energy, solvent-free recovery.116

Another promising approach is the use of choline chloride[thin space (1/6-em)]:[thin space (1/6-em)]lactic acid (1[thin space (1/6-em)]:[thin space (1/6-em)]2) NADES, which enabled the extraction of 1.44 g of carnosic acid 36 and 0.48 g of carnosol 37 per 100 g of Salvia officinalis L., outperforming ScCO2 extraction from both salvia and Rosmarinus officinalis.117,118 Further innovation was achieved by combining NADESs with thermoswitchable ionic liquid systems. A choline chloride–lactic acid/[BMIM]PF6/H2O system enabled homogeneous extraction at 60 °C and spontaneous phase separation upon cooling, allowing in situ fractionation: rosmarinic acid 35 was recovered in the aqueous phase with 89.0% efficiency, while carnosic acid 36 concentrated in the ionic liquid phase with 97.5% recovery.119 This integrated extraction–separation strategy significantly reduces process complexity and eliminates hazardous solvents.

Selectivity can be further tuned by adjusting NADES polarity. For example, menthol: lactic acid systems preferentially extract nonpolar compounds, whereas lactic acid[thin space (1/6-em)]:[thin space (1/6-em)]glucose mixtures target polar phenolics. When used as biphasic systems, both compound classes can be recovered simultaneously under identical conditions. Significantly, NADESs also enhance compound stability: carnosol 36 retained 75% of its antioxidant activity after three months in NADESs, whereas it fully degraded in MeOH within 15 days.120

Complementary separation strategies have further advanced the selective recovery of these key phenolic and diterpenoid constituents. In a comparative study, SPE and liquid–liquid extraction (LLE) were evaluated as practical alternatives to conventional purification methods.

SPE using the macroporous weakly polar resin CAD-40 proved particularly effective for diterpenoid enrichment, affording carnosic acid 36 with 76.8% purity, whereas LLE with AcOEt was better suited for isolating the more polar phenolic fraction from diluted extracts, reaching rosmarinic acid 35 with purities of up to 56.3%. Notably, the combined SPE–LLE approach outperformed traditional column chromatography and previously reported LLE protocols, providing both higher extraction efficiency and improved product quality. Adsorption studies indicated that the separation mechanism is predominantly governed by physical interactions, as evidenced by the good agreement between the experimental data and the Freundlich isotherm.121

In parallel, MAE using PEG-400 further enhanced overall yields under optimised conditions, particularly when phosphoric acid was employed to promote cell wall disruption, while preserving antioxidant activity.122 Complementing these approaches, Mo et al. reported a simple yet highly efficient protocol based on acidic aqueous ethanol extraction followed by multistep purification, achieving carnosic acid 36 purities of 98% or higher and extraction efficiencies above 94%.123

Overall, these studies demonstrate that while classical chromatographic approaches such as Sephadex LH-20 remain valuable benchmarks, emerging green extraction and hybrid SPE–LLE strategies offer superior selectivity, efficiency, and sustainability. The integration of biodegradable solvents reduced solvent consumption, and in situ fractionation represents a decisive step toward cost-effective industrial recovery of rosmarinic acid 35 and abietane diterpenes from Lamiaceae matrices.

3.5.2 Phenolic compounds from citrus: hesperidin and related flavanones. Hesperidin 39 is a flavonoid known to promote wound healing by enhancing collagen synthesis, vasculogenesis, and angiogenesis. Additionally, it has shown potential in preventing the progression of neurodegenerative disorders such as Parkinson's and Alzheimer's disease.124 Rutin 40, another flavonoid with strong antioxidant properties, also contributes to vascular health and has been reported to support and accelerate wound healing (Scheme 9).125
image file: d5su00695c-s9.tif
Scheme 9 Structure of hesperidin 39 and rutin 40.

A recent study developed a green extraction method for isolating hesperidin 39 from fresh orange bagasse using aqueous CaCl2 and pH modulation, thereby avoiding the use of organic solvents and reducing energy input. This eco-friendly process yielded hesperidin 39 at 1.2% concentration and 97.2% purity.126

In contrast, a conventional method using a methanolic extract followed by crystallisation in a water/dichloromethane mixture yielded a higher percentage (2.8%), but with lower purity (89.4%). Notably, the hesperidin 39 obtained via this second method served as the precursor for the synthesis of diosmetin 41, a flavone with documented bioactivity (Scheme 10).127


image file: d5su00695c-s10.tif
Scheme 10 Isolation of hesperidin 39 from orange peel waste and its transformation into diosmetin 41.
3.5.3 Secoiridoids from oleaceae: oleuropein and derivatives. Harvesting olive trees (Olea europaea L.) yields an estimated 25 kg of branches and leaves per tree annually, a biomass stream traditionally regarded as agricultural waste.128 Nevertheless, olive leaves have gained increasing interest in biorefinery and valorisation strategies due to their abundance, renewability, low cost, and, most importantly, their rich and diverse phytochemical composition. This biomass represents a promising raw material for the recovery of bioactive compounds, particularly phenolics and flavonoids, with well-documented antioxidant, antimicrobial, and anti-inflammatory activities. Among these, oleuropein 42 and hydroxytyrosol 43 stand out as the most abundant and biologically active constituents of the olive tree, alongside other valuable compounds such as rutin 40, verbascoside 44, luteolin-7-O-glucoside 45, and catechins (Scheme 11).129
image file: d5su00695c-s11.tif
Scheme 11 Chemical structures of some of the compounds isolated from Olea europaea L.

Several extraction strategies have been explored to effectively recover these compounds, ranging from conventional methods to novel green technologies. Boli et al.130 systematically compared EtOH, water, and choline chloride-based DESs, as well as their mixtures with EtOH or water, demonstrating that solvent polarity and viscosity play a decisive role in extraction performance. While EtOH showed high selectivity toward oleuropein 42, DESs systems exhibited enhanced total phenolic recovery when combined with EtOH, owing to reduced viscosity and improved mass transfer. Moreover, MAE produced phenolic profiles comparable to or superior to those of conventional maceration, while significantly reducing processing time and solvent consumption.

An alternative and selective approach is supercritical antisolvent fractionation (SAF), which utilises ScCO2 as a nonpolar antisolvent. This technique enables the selective precipitation of target compounds while leaving other compounds dissolved. Baldino et al.131 applied SAF to EtOH extracts of olive leaves, increasing the oleuropein 42 concentration from 20% to 36% (w/w) at 150 bar and 35 °C. Chinnarasu et al. demonstrated a similar enhancement using PLE followed by ScCO2 treatment, which tripled the antioxidant activity of the extract.132

Recent studies further support the potential of olive leaf extracts in food preservation and health-related applications. For instance, oleuropein-rich extracts obtained from different olive cultivars have been reported to exhibit high antioxidant and antimicrobial activity against S. aureus and other foodborne pathogens, highlighting their functional role in extending shelf life.133

Comparative evaluations of conventional and intensified extraction techniques—including heat reflux, MAE, UAE, and high-pressure-assisted extraction—have consistently identified oleuropein 42 as the predominant polyphenol in olive leaf extracts, with comparable overall yields across methods.134 Further process optimisation, such as the application of microwave pretreatment prior to UAE, has been shown to substantially enhance total phenolic recovery relative to conventional maceration.135

The effectiveness of UAE is primarily attributed to acoustic cavitation, which facilitates cell wall disruption and the release of intracellular phenolics. In addition to temperature, key operational parameters such as ultrasound frequency and amplitude critically influence extraction efficiency, enabling selective enrichment of oleuropein 42 and luteolin-7-glucoside 45 under mild conditions.136

Pre-extraction processing also plays a decisive role, as drying conditions have been shown to markedly affect phenolic recovery. Room-temperature drying followed by alcoholic extraction has been associated with higher oleuropein 42 yields and enhanced antioxidant activity, reflecting synergistic interactions among phenolic constituents.137

In another study focused on process optimisation, Lama-Muñoz et al. investigated dynamic maceration and PLE using response surface methodologies to evaluate the influence of temperature, EtOH concentration, and leaf moisture. Under optimised PLE conditions (190 °C, 5% moisture and 80% aqueous EtOH), yields of 63.35 g kg−1 of oleuropein 42 and 2.71 g kg−1 of luteolin-7-O-glucoside 45 were achieved, with an associated antioxidant activity of 146.5 mmol Trolox per kg. Notably, reducing the EtOH concentration to 60% resulted in a markedly higher antioxidant capacity (362.55 mmol Trolox per kg), despite a lower total phenolic yield. These findings highlight the complex relationship between phenolic composition and antioxidant efficacy, underscoring the importance of qualitative phenolic profiles over absolute concentrations.138

In conclusion, olive leaves are a sustainable source of bioactive phenolics, with cultivar selection and processing conditions strongly influencing both yield and bioactivity. Among emerging techniques, PLE and SAF stand out for their efficiency, selectivity and scalability, supporting the valorisation of olive leaf biomass within integrated biorefinery and circular bioeconomy frameworks for functional food and nutraceutical applications.

3.5.4 Alkamides and capsaicinoids (capsaicin-like molecules). Capsaicinoids constitute a family of bioactive alkamides responsible for the characteristic pungency and diverse pharmacological properties of capsicum species. Among them, capsaicin 46 (Scheme 12) is the most abundant and extensively studied compound. Capsaicin 46 exhibits well-documented analgesic activity, particularly in the management of chronic pain, and has also been reported to exert anticancer effects through multiple molecular mechanisms. Furthermore, several studies have demonstrated that capsaicin 46 consumption can suppress appetite, enhance energy expenditure, and support weight management, suggesting its potential role in obesity management.139 In addition to these effects, capsaicinoids display strong antioxidant activity, efficiently scavenging reactive oxygen species (ROS) implicated in oxidative stress and the progression of chronic diseases.140
image file: d5su00695c-s12.tif
Scheme 12 Chemical structure of some alkamides of biological interest.

Beyond capsaicinoids, other structurally related bioactive alkamides—such as spilanthol (also known as affinin) 48, the major N-alkylamide of Acmella oleracea—share comparable physicochemical properties, biological activities, and technological challenges during extraction and purification. These capsaicin-like molecules are typically amphiphilic, thermolabile, and present at relatively low concentrations in complex plant matrices, making their selective and sustainable recovery particularly demanding.141

To overcome the limitations of conventional capsaicinoids extraction methods, such as Soxhlet, maceration, and HD, considerable effort has been devoted to developing alternative extraction techniques. Traditional approaches are often characterised by long extraction times, high solvent consumption, limited selectivity and the risk of thermal degradation of sensitive phytochemicals. One of the recently reported approaches for obtaining high-purity capsaicinoids from ground habanero pepper (Capsicum chinense) involves a two-step MAE process. In this strategy, the milled chilli matrix is first irradiated under solvent-free conditions, followed by microwave irradiation in EtOH. This intensified MAE protocol achieved a total capsaicinoid recovery of 91.84%, with capsaicin 46 as the major component (56.22%), followed by dihydrocapsaicin 47 (35.62%). Compared with conventional Soxhlet extraction, the MAE process provided higher extraction efficiency, significantly reduced processing times and lower energy consumption, demonstrating its potential as a more sustainable alternative for the selective recovery of capsaicinoids from habanero peppers.142

Aqueous two-phase systems (ATPS) are formed by two hydrophilic components—such as alcohols, polymers, ionic liquids, or inorganic salts—that spontaneously separate into two immiscible aqueous phases. Target compounds distribute between these phases according to their physicochemical properties and the system's specific composition. Using this approach, Zhao et al. developed a three-step separation and purification strategy for capsaicin 40 from capsicum oleoresin. In the initial extraction step, crude capsaicin 40 was recovered using an EtOH–K2CO3-based ATPS, yielding an 85.4% recovery. Subsequent purification was performed in two chromatographic steps using D101 macroporous resin, followed by SKP-10-4300 reversed-phase resin, resulting in an overall increase in capsaicin 40 purity from 7% to 85%.143 Similarly, Fan et al. reported a maximum capsaicin recovery of 95.5% using an ethylene oxide–propylene oxide copolymer–K2HPO4–EtOH ATPS, followed by adsorption on macroporous resin to reach purities above 85%.144 Comparable sustainable strategies have recently been extended to spilanthol 41, which has been successfully extracted using NADES combined with simplified SPE protocols based exclusively on ethanol–water systems. These approaches achieved spilanthol 41 purities exceeding 90% while avoiding halogenated solvents and reducing chromatographic complexity, thereby closely paralleling ATPS-based capsaicin purification in terms of green chemistry principles and process efficiency.145

Beyond improvements in extraction efficiency, increasing attention has been directed towards the development of sustainable separation and purification strategies for capsaicinoids. Despite their effectiveness, ATPS- and resin-based purification strategies often rely on multiple chromatographic steps, which can increase operational costs and limit large-scale applicability. Similar limitations have been highlighted in the purification of spilanthol, where conventional column chromatography or solvent-intensive clean-up procedures, although effective, pose challenges related to solvent use, scalability, and compound stability.146 To address these issues, hybrid approaches combining MAE with ATPS have been proposed. For instance, the elimination of chromatographic steps through MAE of Capsicum chinense var. cumari-do-Pará, followed by an EtOH–NaH2PO4 ATPS, enabled the isolation of capsaicin 40 with an extraction efficiency of 85.6%.147

Collectively, these studies demonstrate that capsaicinoids, exemplified by capsaicin 40, and structurally related alkamides such as spilanthol 41 can be addressed within a unified conceptual framework for sustainable extraction and purification. The convergence of MAE, ATPS, NADES, and low-solvent SPE approaches underscores the potential for transferable green methodologies applicable to a broader class of bioactive N-alkylamides derived from biomass waste.

3.6 Agrochemicals

The intensive use of synthetic agrochemicals has ensured high agricultural productivity but has also raised concerns regarding environmental persistence, non-target toxicity, and the rapid development of pest resistance, thereby accelerating the search for bio-based alternatives derived from natural sources.148,149 In this context, plant secondary metabolites recovered from agro-industrial waste have emerged as promising candidates for sustainable pest management due to their insecticidal, antifeedant, antiviral, and growth-regulating activities. Among these, limonoids from citrus residues stand out as key bioactive constituents, whose occurrence in both aglycone and glycosylated forms enables selective recovery and functional diversification. Moreover, the variability of limonoid profiles across citrus species, cultivars, and developmental stages highlights the importance of rational biomass selection when designing efficient and sustainable valorisation strategies.150
3.6.1 Limonoids: limonin as a lead agrochemical. Limonoids constitute a distinctive class of highly oxygenated tetranortriterpenoids predominantly found in the Rutaceae and Meliaceae families. Among them, limonin 50 (Scheme 13) is consistently reported as the most abundant limonoid in citrus fruits and their industrial by-products, including seeds, peels, and pomace. Its widespread distribution, chemical stability, and well-defined molecular scaffold have positioned limonin 50 as a primary target for recovery from citrus waste streams.151
image file: d5su00695c-s13.tif
Scheme 13 Representative structures of major citrus limonoids.

Beyond its abundance, limonin 50 displays a broad spectrum of biological activities relevant to crop protection, including insecticidal, antifeedant, insect growth–regulatory, and antiviral effects.152 This multifunctionality is particularly advantageous for integrated pest management strategies, where compounds that act through multiple biological pathways can help mitigate the development of pest resistance. Nevertheless, the moderate intrinsic potency of limonin 50 has driven sustained efforts to enhance its performance through optimised extraction strategies and targeted structural modification.153

From a processing perspective, significant advances have been made in the sustainable recovery of limonin 50 from citrus biomass. ScCO2 extraction has emerged as an effective green technology for selectively isolating limonoid aglycones, offering high extraction efficiency while minimising thermal degradation. Several studies have demonstrated that careful optimisation of pressure, temperature, and co-solvent composition enables efficient recovery of limonin 50 from citrus seeds and peels, supporting the scalability of this approach.154

Complementary to scCO2-based approaches, hydrotropic extraction has been proposed as an innovative aqueous strategy that simultaneously recovers water-insoluble limonoid aglycones and water-soluble limonoid glucosides in a single step. Using Citrus aurantium seeds as a model matrix, Dandekar et al. demonstrated a hydrotropy-assisted extraction–purification process based on sodium cumene sulphonate, followed by adsorption onto a polystyrenic SP700 resin and gradient elution with water/MeOH mixtures. This methodology enabled the isolation of three structurally distinct limonoids—limonin 50 (410 mg), deacetyl nomilinic acid glucoside 52 (310 mg), and deacetyl nomilin 54 (155 mg)—from 250 g of seed material. Notably, coupling hydrotropy with resin-based fractionation enabled efficient separation across a broad polarity range while substantially reducing organic solvent consumption, positioning this approach as a viable alternative to supercritical and solvent-intensive processes.155

In contrast to physicochemical extraction methods, enzymatic strategies offer a biologically inspired route for limonoid recovery under particularly mild conditions. An early contribution was reported by Lim et al., who investigated the enzymatic hydrolysis of citron (Citrus junos) processing waste using pectinase and cellulase. Through response surface optimisation, limonin 50 concentrations of up to 3.5 mg per 100 g of processed waste were achieved at approximately 50 °C and pH ≈ 5, together with the co-recovery of structurally related limonoids such as nomilin 53.156

Building on this work, Ramos-Ibarra et al. demonstrated that enzyme-assisted treatment of Citrus sinensis and Citrus aurantiifolia seeds using a commercial pectinase–cellulase complex significantly enhanced limonin 50 releases. Under optimised conditions, limonin 43 recoveries reached 3.7 mg per g dry seed, corresponding to approximately a two-fold increase relative to non-enzymatic or conventional solvent-based extractions.157

Overall, limonin 50 exemplifies how a naturally abundant metabolite derived from citrus industrial residues can be valorised as a lead compound for sustainable agrochemical development. The convergence of green extraction technologies highlights the strong potential of limonoids as renewable, multifunctional building blocks for environmentally responsible crop protection strategies.

4 Techno-economic assessment of bioactive recovery pathways

4.1 Key economic indicators and assumptions

Techno-economic assessment (TEA) is a key tool for determining the industrial viability of bioactive compound recovery from biomass waste streams, particularly when embedded within integrated biorefinery schemes aligned with circular bioeconomy principles. Rather than focusing solely on individual cost items, recent studies emphasise that economic performance is primarily governed by process integration, co-product valorisation, and long-term operational stability, as neglecting these factors frequently leads to unrealistic profitability projections.158

Across reported TEA case studies, a limited number of parameters consistently dominate overall process economics. These include process throughput, equipment lifetime, and the efficiency of solvent, water, or sorbent regeneration, which often exert a stronger influence on operating costs than energy consumption itself.159 This is especially evident in adsorption- and membrane-based recovery systems, where material durability and fouling behaviour directly determine replacement frequency and long-term cost structures.160

Feedstock availability and logistics represent another critical, yet frequently underestimated, economic constraint. Although biomass residues are commonly assumed to be low-cost or cost-free, expenses associated with collection, stabilisation, drying, storage, and transport can account for a substantial fraction of Operational Expenditure (OPEX), particularly for wet, bulky, or seasonally available matrices such as fruit pomace, winery residues, or algal biomass. These constraints become increasingly relevant at an industrial scale, where continuous operation requires reliable, year-round supply chains.159,161

The economic performance of green extraction technologies is also highly sensitive to assumptions regarding solvent recovery, energy integration, and scale-dependent efficiencies. Hydrothermal, membrane-based, and adsorption-driven processes show markedly improved competitiveness upon scale-up when heat recovery, process intensification, and renewable energy integration are implemented, whereas laboratory-scale assumptions often underestimate the impact of solvent recycling efficiency and sorbent lifespan on unit production costs.161

Finally, TEA outcomes are strongly market dependent. High-value pharmaceutical and nutraceutical applications can sustain higher production costs due to elevated market prices and strict purity requirements, while food, cosmetic, and agrochemical uses demand high-throughput, cost-efficient processes operating at moderate purity levels. This market-driven cost tolerance and the associated trade-offs between economic performance and sustainability objectives are a recurring conclusion across TEA and combined TEA–life cycle assessment (LCA) studies on phenolics, polysaccharides, and antioxidant extracts.162

4.2 Process-compound coupling, case studies, and scaling-up considerations

Case studies reported in the literature clearly demonstrate that the techno-economic viability of bioactive compound recovery pathways depends strongly on the coupling of specific phytochemicals with appropriate extraction and purification technologies, as well as on their integration within multiproduct and cascade-based processing schemes. In general, approaches enabling the sequential recovery of several compound classes from a single biomass consistently outperform isolated, single-product processes by distributing capital and operating costs across multiple revenue streams and improving overall biomass utilisation.163

A representative example is the techno-economic evaluation of sequential hydrothermal extraction for potato peel valorisation, where multi-stage processes allowing the recovery of polyphenols, glycoalkaloids, and polysaccharides achieved superior economic performance compared with single-stage routes, despite higher capital expenditure associated with increased process complexity.158 Similar advantages have been reported for citrus peel and olive-derived by-products, where integrated biorefinery configurations combine early recovery of volatile fractions, such as essential oils or limonene, with subsequent solvent-based, membrane-assisted, or adsorption-driven extraction of phenolic compounds.161a,164

For phenolic-rich liquid and semi-solid residues, including olive mill wastewater and processing streams from Lamiaceae and Oleaceae species, adsorption–desorption approaches based on polymeric resins or membrane concentration have emerged as economically competitive alternatives to solvent-intensive extraction. TEA consistently identify resin lifespan, regeneration efficiency, and fouling behaviour as dominant contributors to operating costs, frequently exceeding the impact of energy consumption.161a

Beyond terrestrial biomass, cascade extraction strategies have also been validated for marine resources such as brown macroalgae. Combined TEA–LCA studies demonstrate that integrated biorefinery concepts can achieve favourable economic and environmental performance when feedstock costs, extraction efficiency, and membrane performance are carefully optimised, with co-product valorisation playing a decisive role in achieving positive net present values at an industrial scale.161

Recent work on walnut by-products (Juglans regia L.) provides a particularly illustrative example of successful process scalability under realistic conditions. In this study, polyphenols were extracted from walnut shell and pruning residues using an ethanol–water system under mild operating conditions. While laboratory-scale optimisation identified optimal extraction parameters (60% ethanol, solid-to-solvent ratio 1[thin space (1/6-em)]:[thin space (1/6-em)]4, particle size 6 mm, 25 °C, 1.5 h), subsequent validation at semi-industrial scale yielded higher extraction yields than those at laboratory scale, reaching 35.4% for walnut shells and 23.3% for pruning residues.165

Selected case studies on lycopene extraction from tomato processing residues further reinforce the importance of integrated economic and environmental evaluation. Although multiple extraction technologies have been demonstrated at laboratory scale, their industrial feasibility remains strongly dependent on capital investment, operating costs, energy demand, and solvent recovery efficiency, and comprehensive comparative LCA–TEA studies across alternative technologies remain limited.166 Membrane-based pervaporation has emerged as a promising option, combining moderate capital requirements with comparatively low environmental impacts, although membrane replacement frequency and solvent selection remain critical economic drivers.167 In contrast, supercritical CO2 extraction can deliver higher profitability under optimised conditions, but this advantage is often offset by increased capital investment and energy consumption.166

Comparable conclusions have been reported for limonene recovery from citrus processing residues, where process simulation and TEA indicate that high-purity D-limonene can be obtained via conventional separation routes such as vacuum fractional distillation, with economic performance strongly dependent on production scale and feedstock sourcing strategies.168 Although ScCO2-based routes can achieve near-complete recovery, their higher energy demand and solvent circulation requirements significantly influence manufacturing costs.169 Sustainability-oriented assessments consistently show that limonene production is most competitive when embedded in fully integrated orange peel biorefineries, coupling essential oil and polyphenol recovery with downstream processes such as enzymatic saccharification and anaerobic digestion.170

Finally, case studies on rosemary biomass demonstrate that integrated and intensified extraction schemes can significantly improve the economic performance of abietane-type diterpene recovery. Process intensification strategies combining ScCO2 extraction and pressurised water extraction within a single multipurpose unit reduce annual production costs by approximately 25–30% compared with single-step supercritical extraction, reinforcing the industrial potential of integrated, multiproduct biorefinery schemes.171

From a scaling-up perspective, laboratory-optimised processes face additional challenges, including limitations in mass and heat transfer, large-volume solvent handling, membrane fouling, and sorbent degradation when processing complex biomass matrices. Studies on NADES-, hydrothermal-, and membrane-based systems indicate that viscosity, fouling propensity, and cleaning frequency can significantly affect both capital and operating costs at an industrial scale.160,161 Regulatory constraints related to solvent residues and product specifications further increase economic uncertainty, particularly for food and pharmaceutical applications.

Despite these challenges, pilot- and demonstration-scale studies increasingly confirm that well-designed, modular processes incorporating heat integration, solvent reuse, and co-product valorisation can achieve competitive economic performance. Early integration of TEA, combined with sensitivity and scenario analysis, is therefore essential to guide technology selection, prioritise research efforts, and minimise scale-up risks in the sustainable recovery of bioactive compounds from biomass waste streams.

5 Environmental, circularity, and societal dimensions of bioactive recovery

Environmental assessment, particularly through LCA, plays a central role in determining whether bioactive compound recovery pathways genuinely deliver sustainability benefits. Although green extraction technologies are frequently promoted as environmentally friendly, their overall environmental performance depends strongly on system-level factors, including energy sources, solvent production routes, process efficiency, and scale of operation. For example, ScCO2 extraction may exhibit higher energy demands than conventional solvent-based methods; however, these impacts can be substantially mitigated through renewable energy integration, efficient heat recovery, and CO2 recycling strategies.

LCA studies consistently demonstrate that the valorisation of biomass waste into high-value phytochemicals can significantly reduce environmental burdens when compared with conventional disposal scenarios such as landfilling or incineration. Avoiding impacts associated with waste management and the displacement of fossil-based or synthetically produced additives contributes positively to overall environmental performance. Nevertheless, comprehensive and harmonised LCA data remain limited for many emerging extraction and purification technologies, highlighting the need for consistent methodological frameworks to enable meaningful cross-comparisons and informed decision-making.

Beyond environmental performance, bioactive recovery from agro-industrial residues aligns directly with the principles of the circular bioeconomy by promoting resource efficiency, waste minimisation, and value retention. Transforming low-value or problematic waste streams into functional ingredients closes material loops and creates additional revenue streams for agricultural and food-processing sectors. Integrated biorefinery approaches, in which multiple products are sequentially recovered from the same biomass, exemplify circular design by maximising resource utilisation while simultaneously enhancing economic resilience and reducing environmental footprints. Moreover, decentralised valorisation of locally generated residues can strengthen regional bioeconomies, particularly in agricultural areas where waste accumulation poses both environmental and logistical challenges.

Social acceptance and regulatory compliance are equally decisive for the successful implementation of bioactive recovery pathways. Regulatory frameworks governing food, pharmaceutical, cosmetic, and agrochemical applications impose strict requirements on raw material traceability, solvent selection, residual contaminants, and product safety. While compliance with these regulations can increase development costs and complexity, it also provides market confidence and facilitates consumer trust. From a social perspective, biomass valorisation can support rural development, job creation, and income diversification for agro-industrial stakeholders. Transparent communication about the safety, quality, and sustainability of products derived from biomass residues is essential to address potential consumer concerns about the use of “waste-derived” materials. When robust regulatory compliance is combined with credible environmental assessment and circular design principles, bioactive recovery from biomass waste can achieve broad societal acceptance across multiple industrial sectors.

6 Conclusions and future perspectives

The valorisation of plant-based biomass waste as a renewable source of high-value phytochemicals represents a strategically important pathway at the convergence of Green Chemistry, Circular Bioeconomy, and sustainable industrial development. As illustrated throughout this review, a wide diversity of bioactive compounds, including pigments, flavours and fragrances, pharmacologically relevant metabolites, lipophilic constituents, phenolics, and agrochemical precursors, can be selectively recovered from agro-industrial residues using both established and emerging green extraction and purification technologies, supporting the development of more sustainable and circular bio-based value chains.

Beyond extraction efficiency alone, techno-economic and environmental analyses demonstrate that industrial viability critically depends on intelligent process integration, solvent recovery and reuse, energy optimisation, and alignment with end-use market requirements. Integrated biorefinery concepts, particularly those enabling multiproduct recovery and cascade valorisation, consistently outperform single-product approaches by enhancing resource efficiency, economic resilience, and environmental performance. Nevertheless, translating these strategies into industrial practice will require further efforts in process integration, scale-up validation, and the adoption of standardised sustainability metrics to enable fair comparisons between competing technologies.

From a sustainability perspective, combined TEA–LCA studies highlight that the environmental benefits of bioactive recovery are strongly context-dependent, being maximised when waste-derived feedstocks displace fossil-based or synthetically produced ingredients and when avoided waste management impacts are properly accounted for. However, the limited availability of comprehensive, comparable life-cycle assessment data for emerging extraction technologies underscores the need for harmonised assessment frameworks and early-stage sustainability screening.

Future research should therefore prioritise the systematic integration of techno-economic assessment, life cycle analysis, and regulatory considerations from the earliest stages of process development. Greater emphasis on scalable multiproduct recovery schemes, digital process optimisation, and decentralised, region-specific valorisation strategies will be essential to strengthen local bioeconomies and reduce logistical and environmental burdens. In parallel, regulatory-aware process design and transparent communication of safety and sustainability attributes will be critical to foster market acceptance, particularly in food, pharmaceutical, cosmetic, and agrochemical applications.

Ultimately, the successful implementation of green and integrated recovery strategies has the potential to transform agro-industrial residues from an environmental liability into a cornerstone of resilient, sustainable, and competitive bio-based industries. By coupling chemical innovation with system-level thinking, biomass waste valorisation can play a decisive role in advancing circular production models and supporting the transition toward a more sustainable industrial future.

Author contributions

E. I. J. R. and R. B. V.: writing – original draft preparation; R. H. S. and I. C. G.: writing – review; Mariana Macías-Alonso & Joaquin G. Marrero: conceptualization, supervision, review, and editing.

Conflicts of interest

The authors declare no conflicts of interest.

Abbreviations

AcOHAcetic acid
AcOEtEthyl acetate
APWArtemisinin production waste
ATPSAqueous two-phase systems
CACorosolic acid
CAPEXCapital expenditure
CBDCannabidiol
CBDACannabidiolic acid
CLCellulase
CPCCentrifugal partition chromatography
CPMECyclopentyl methyl ether
DESsDeep eutectic solvents
DMCDimethyl carbonate
DDDeodorizer distillate
DWDry weight
EOsEssential oils
EtOHEthanol
FAMEsFatty acid methyl esters
FASEsFatty acid sterol esters
FFAFree fatty acids
HDConventional hydrodistillation
nHexn-Hexane
ILsIonic liquids
LLELiquid–liquid extraction
LCALife cycle assessment
MAMaslinic acid
MAPsMedicinal and aromatic plants
MAEMicrowave-assisted extraction
MAHDMicrowave-assisted hydrodistillation
MeOHMethanol
2-MeTHF2-Methyltetrahydrofuran
MtBEMethyl tert-butyl ether
NADESNatural deep eutectic solvents
OAOleanolic acid
OLEOleuropein
OPEXOperational expenditure
PGPolygalacturonase
PLPectin lyase
PLEPressurised liquid extraction
PTAsPentacyclic triterpenes acids
ROSReactive oxygen species
RODDRapeseed oil deodoriser distillate
SAFSupercritical antisolvent fractionation
ScCO2Supercritical carbon dioxide
SFESupercritical fluid extraction
SLESolid–liquid extraction
SLMESolvent-less microwave extraction
SODDSoybean oil deodoriser distillate
SPESolid phase extraction
TEATechno-economic assessment
Δ9-THCDelta-9-tetrahydrocannabinol
UAUrsolic acid
UAEUltrasound-assisted extraction
WHOWorld health organisation
XLXylanase

Data availability

Data sharing is not applicable to this article as no new data were created or analyzed in this study.

Acknowledgements

We gratefully acknowledge the support of the Secretaría de Ciencia, Humanidades, Tecnología e Innovación (grant number CBF-2025-I-2852) and the Secretaría de Investigación y Posgrado del IPN (SIP-IPN).

Notes and references

  1. M. Di Marco, O. Venter, H. P. Possingham and J. E. M. Watson, Nat. Commun., 2018, 9, 4621 CrossRef PubMed.
  2. C. J. C. Jabbour, P. D. C. Fiorini, C. W. Y. Wong, D. Jugend, A. B. L. D. S. Jabbour, B. M. R. P. Seles, M. A. P. Pinheiro and H. M. R. da Silva, Resour. Policy, 2020, 66, 101596 CrossRef.
  3. J. Kirchherr, D. Reike and M. Hekkert, Resour., Conserv. Recycl., 2017, 127, 221–232 CrossRef.
  4. European Commission, Review of the 2012 European Bioeconomy Strategy, https://op.europa.eu/en/publication-detail/-/publication/c2f36c72-2e59-11e8-b5fe-01aa75ed71a1/language-en, accessed 25 oct 2025 Search PubMed.
  5. M. Mujtaba, L. F. Fraceto, M. Fazeli, S. Mukherjee, S. M. Savassa, G. A. de Medeiros, A. E. S. Pereira, S. D. Mancini, J. Lipponen and F. Vilaplana, J. Cleaner Prod., 2023, 402, 136815 CrossRef CAS.
  6. (a) S. Theodoridis, E. G. Drakou, T. Hickler, M. Thines and D. Nogues-Bravo, Lancet Planet. Health, 2023, 7, e155–e163 CrossRef PubMed; (b) R. Ksiezopolski, E. Maré, G. Olsanska, A. De Paoli, W. De Jongh, C. Schunko, J. Rode, R. Moya and D. Argyropoulos, Wild collection: Recommendations to avoid over-exploitation and to promote sustainable use of wild resources, EIPAGRI Focus Group Plant-Based Medicinal and Cosmetic Products, https://ec.europa.eu/eip/agriculture/sites/default/files/fg35_mp5_wildcollection_2020_en.pdf, accessed 25 oct 2025.
  7. F. Rabizadeh, M. S. Mirian, R. Doosti, R. Kiani-Anbouhi and E. Eftekhari, J. Evidence-Based Complementary Altern. Med., 2022, 2022, 8022599 Search PubMed.
  8. J. Olofsson and P. Börjesson, J. Cleaner Prod., 2018, 196, 997–1006 CrossRef.
  9. M. Carus, Ind. Biotechnol., 2017, 13, 41–51 CrossRef.
  10. A. Bauer and M. Brönstrup, Nat. Prod. Rep., 2014, 31, 35–60 RSC.
  11. D. J. Newman and G. M. Cragg, J. Nat. Prod., 2020, 83, 770–803 CrossRef CAS PubMed.
  12. V. G. Zuin and L. Z. Ramin, Top. Curr. Chem., 2018, 376, 3 CrossRef PubMed.
  13. (a) A. Saha and B. B. Basaka, Ind. Crops Prod., 2020, 145, 111979 CrossRef CAS; (b) M. Mathur, N. Hans, F. Naaz, S. N. Naik, K. K. Pant and A. Malik, J. Cleaner Prod., 2022, 373, 133925 CrossRef CAS; (c) M. Perra, A. Cuena-Lombraña, G. Bacchetta, M. L. Manca, M. Manconi, R. G. Maroun, A. Muntoni, C. I. G. Tuberoso, K. A. Gil and G. De Gioannis, Sustainability, 2022, 14, 10690 CrossRef CAS; (d) Y. H. Chai, S. Yusup, W. N. A. Kadir, C. Y. Wong, S. S. Rosli, M. S. H. Ruslan, B. L. F. Chin and C. L. Yiin, Sustainability, 2021, 13, 233 CrossRef CAS; (e) C. Filote, S. C. R. Santos, V. I. Popa, C. M. S. Botelho and I. Volf, Environ. Chem. Lett., 2021, 19, 969–1000 CrossRef CAS.
  14. M. J. Page, J. E. McKenzie, P. M. Bossuyt, I. Boutron, T. C. Hoffmann, C. D. Mulrow, L. Shamseer, J. M. Tetzlaff, E. A. Akl, S. E. Brennan, R. Chou, J. Glanville, J. M. Grimshaw, A. Hróbjartsson, M. M. Lalu, T. Li, E. W. Loder, E. Mayo-Wilson, S. McDonald, L. A. McGuinness, L. A. Stewart, J. Thomas, A. C. Tricco, V. A. Welch, P. Whiting and D. Moher, BMJ, 2021, 372, n71 CrossRef PubMed.
  15. (a) E. O. Alegbe and T. O. Uthman, Heliyon, 2024, 10, e33646 CrossRef CAS PubMed; (b) A. Negi, Sustainable Chem., 2025, 6, 23 CrossRef CAS.
  16. (a) T. Tufail, H. B. Ul Ain, S. Noreen, A. Ikram, M. T. Arshad and M. A. Abdullahi, Food Sci. Nutr., 2024, 12, 8715–8741 CrossRef CAS PubMed; (b) M. Viuda-Martos, E. Sánchez-Zapata, E. Sayas-Barberá, E. Sendra, J. A. Pérez-Álvarez and J. Fernández-López, Crit. Rev. Food Sci. Nutr., 2014, 54, 1032–1049 CrossRef CAS PubMed.
  17. (a) M. M. Poojary and P. Passamonti, Food Chem., 2015, 188, 84–91 CrossRef CAS PubMed; (b) D. T. Tran, L. T. H. Nguyen, C. N. Nguyen, B. Nicolaï and D. Picha, Pol. J. Food Nutr. Sci., 2023, 73, 205–213 CrossRef CAS; (c) A. Zuorro, Molecules, 2020, 25, 2038 CrossRef CAS PubMed.
  18. (a) L. Marinaccio, G. Zengin, O. Bender, A. Cichelli, E. N. A. Stefanucci and A. Mollica, Food Chem. Adv., 2024, 4, 100656 CrossRef; (b) S. Kumar, A. Rawson, A. Kumar, S. CK, S. Vignesh and N. Venkatachalapathy, Int. J. Food Sci. Technol., 2023, 58, 2141–2150 CrossRef CAS.
  19. M. Kehili, S. Sayadi, F. Frikha, A. Zammel and N. Allouche, Food Bioprod. Process., 2019, 117, 321–328 CrossRef CAS.
  20. S. Rahimi and M. Mikani, Microchem. J., 2019, 146, 1033–1042 CrossRef CAS.
  21. (a) G. Campos-Lozada, X. A. Pérez-Marroquín, G. Callejas-Quijada, R. G. Campos-Montiel, R. G. Campos-Montiel, A. Morales-Peñaloza, A. León-López and G. Aguirre-Álvarez, Antioxidants, 2022, 11, 1404 CrossRef CAS PubMed; (b) K. Mavridis, N. Todas, D. Kalompatsios, V. Athanasiadis and S. I. Lalas, Horticulturae, 2025, 11, 71 CrossRef.
  22. (a) T. Baysal, S. Ersus and D. A. J. Starmans, J. Agric. Food Chem., 2000, 48(11), 5507–5511 CrossRef CAS PubMed; (b) E. Sabio, M. Lozano, V. Montero de Espinosa, R. L. MendesA, P. PereiraA, F. Palabra and J. A. Coelho, Ind. Eng. Chem. Res., 2003, 42(25), 6641–6646 CrossRef CAS; (c) J. Shi, M. Khatri, S. J. Xue, G. S. Mittal, Y. Ma and D. Li, Sep. Purif. Technol., 2009, 66, 322–328 CrossRef CAS; (d) B. P. Nobre, A. F. Palavra, F. L. P. Pessoa and R. L. Mendes, Food Chem., 2009, 116, 680–685 CrossRef CAS.
  23. J. P. S. Aniceto, V. H. Rodrigues, I. Portugal and C. M. Silva, Processes, 2022, 10, 28 CrossRef CAS.
  24. (a) S. Machmudah, Zakaria, S. Winardi, M. Sasaki, M. Goto, N. Kusumoto and K. Hayakawa, J. Food Eng., 2012, 108, 290–296 CrossRef CAS; (b) H. D. F. Q. Barros, R. Grimaldi and F. A. Cabral, J. Supercrit. Fluids, 2017, 120, 1–6 CrossRef CAS; (c) J. Shi, C. Yi, S. J. Xue, Y. Jiang, Y. Ma and D. Li, J. Food Eng., 2009, 93, 431–436 CrossRef CAS.
  25. P. Squillace, F. Adani and B. Scaglia, Food Chem., 2020, 315, 126224 CrossRef CAS PubMed.
  26. C. Lombardelli, K. Liburdi, I. Benucci and M. Esti, Food Bioprod. Process., 2020, 121, 43–53 CrossRef CAS.
  27. (a) R. Lavecchia and A. Zuorro, Eur. Food Res. Technol., 2008, 228, 153–158 CrossRef CAS; (b) G. Catalkaya and D. Kahveci, Sep. Purif. Technol., 2019, 219, 55–63 CrossRef CAS; (c) A. Zuorro, M. Fidaleo and R. Lavecchia, Enzyme Microb. Technol., 2011, 49, 567–573 CrossRef CAS PubMed.
  28. S. Cuccolini, A. Aldini, L. Visai, M. Daglia and D. Ferrari, J. Agric. Food Chem., 2013, 61, 1646–1651 CrossRef CAS PubMed.
  29. M. R. Ladole, R. R. Nair, Y. D. Bhutada, V. D. Amritkar and A. B. Pandit, Ultrason. Sonochem., 2018, 48, 453–462 CrossRef CAS PubMed.
  30. L. Xu and X. Wang, Int. J. Mol. Sci., 2025, 26, 5767 CrossRef CAS PubMed.
  31. (a) D. Naviglio, F. Pizzolongo, L. Ferrara, A. Aragòn and A. Santini, J. Sci. Food Agric., 2008, 88, 2414–2420 CrossRef CAS; (b) M. Gallo, A. Formato, M. Ciaravolo, C. Langella, R. Cataldo and D. Naviglio, Eur. Food Res. Technol., 2019, 245, 1767–1775 CrossRef CAS.
  32. (a) J. B. Sharmeen, F. M. Mahomoodally, G. Zengin and F. Maggi, Molecules, 2021, 26, 666 CrossRef CAS PubMed; (b) K. R. Reshna, S. Gopi and P. Balakrishnan, in Flavors and Fragrances in Food Processing: Preparation and Characterization Methods, ed. P. Balakrishnan and S. Gopi, American Chemical Society, Washington, DC, 1er edn, 2022, ch. 1, pp. 1–19 Search PubMed.
  33. (a) A. J. Vieira, F. P. Beserra, M. C. Souza, B. M. Totti and A. L. Rozza, Chem.-Biol. Interact., 2018, 283, 97–106 CrossRef CAS PubMed; (b) M. Pagliaro, A. S. Fabiano-Tixier and R. Ciriminna, Green Chem., 2023, 25, 6108–6119 RSC; (c) B. Ozturk, J. Winterburn and M. Gonzalez-Miquel, Biochem. Eng. J., 2019, 151, 107298 CrossRef CAS.
  34. (a) S. A. Siddiqui, M. J. Pahmeyer, E. Assadpour and S. M. Jafari, Ind. Crops Prod., 2022, 177, 114484 CrossRef CAS; (b) F. Chemat, M. Abert Vian, H. K. Ravi, B. Khadhraoui, S. Hilali, S. Perino and A. F. Tixier, Molecules, 2019, 24, 3007 CrossRef CAS PubMed; (c) C. G. Lopresto, F. Petrillo, A. A. Casazza, B. Aliakbarian, P. Perego and V. Calabrò, Sep. Purif. Technol., 2014, 137, 13–20 CrossRef CAS.
  35. B. Ozturk, J. Winterburn and M. Gonzalez-Miquel, Biochem. Eng. J., 2019, 151, 107298 CrossRef CAS.
  36. A. L. B. Días, A. C. de Aguiar and M. A. Rostagno, Ultrason. Sonochem., 2021, 74, 105584 CrossRef PubMed.
  37. S. Yasumoto, A. T. Quitain, M. Sasaki, H. Iwai, M. Tanaka and M. Hoshino, J. Supercrit. Fluids, 2015, 104, 104–111 CrossRef CAS.
  38. C. G. Lopresto, A. Meluso, G. Di Sanzo, S. Chakraborty and V. Calabrò, Euro-Mediterr. J. Environ. Integr., 2019, 4, 31 CrossRef.
  39. S. Safranko, I. Corkovic, I. Jerkovic, M. Jakovljevic, K. Aladic, D. Subaric and S. Joki, Foods, 2021, 10, 1043 CrossRef CAS PubMed.
  40. M. Melikoglu, Sustain. Chem. Clim. Action, 2025, 7, 100122 CrossRef.
  41. A. Martínez-Abad, M. Ramos, M. Hamzaoui, S. Kohnen, A. Jiménez and M. C. Garrigós, Foods, 2020, 9, 1493 CrossRef PubMed.
  42. M. T. Golmakani and M. Moayyedi, J. Essent. Oil Res., 2016, 28, 272–282 CrossRef CAS.
  43. T. M. Attard, B. Watterson, V. L. Budarin, J. H. Clark and A. J. New, J. Chem., 2014, 38, 2278–2283 CAS.
  44. M. Auta, U. Musa, D. G. Tsado, A. A. Faruq, A. G. Isah, S. Raji and C. Nwanisobi, Chem. Eng. Commun., 2018, 205, 789–796 CrossRef CAS.
  45. S. Yeasmin, J. Uddin, S. S. Dey, J. Barmon, N. T. Ema, G. M. M. Rana, M. Rahman, M. Begum, L. Ferdousi, S. Ahmed, S. Khan, H. Khatun and A. A. Muzahid, Curr. Res. Green Sustainable Chem., 2024, 8, 100413 CrossRef.
  46. J. Bustamante, S. van Stempvoort, M. García-Gallarreta, J. A. Houghton, H. K. Briers, V. L. Budarin, A. S. Matharu and J. H. Clark, J. Cleaner Prod., 2016, 137, 598–605 CrossRef CAS.
  47. L. Shen, S. Pang, M. Zhong, Y. Sun, A. Qayum, Y. Liu, A. Rashid, B. Xu, Q. Liang, H. Ma and X. Ren, Ultrason. Sonochem., 2023, 101, 106646 CrossRef CAS PubMed.
  48. R. D. Khandare, P. D. Tomke and V. K. Rathod, Chem. Eng. Process. Process Intensif., 2021, 159, 108181 CrossRef CAS.
  49. I. M. Bodea, A. G. Pérez, G. M. Cătunescu and A. Palop, Food Bioprocess Technol., 2025, 18, 7060–7082 CrossRef CAS.
  50. J. González-Rivera, A. Spepi, C. Ferrari, C. Duce, I. Longo, D. Falconieri, A. Pirasd and M. R. Tinèa, Green Chem., 2016, 18, 6482–6492 RSC.
  51. (a) A. G. Atanasov, S. B. Zotchev, V. M. Dirsch and C. T. Supuran, Nat. Rev. Drug Discovery, 2021, 20, 200–216 CrossRef CAS PubMed; (b) S. B. Bharate and C. W. Lindsley, J. Med. Chem., 2024, 67, 20723–20730 CrossRef CAS PubMed.
  52. C. Espro, E. Paone, F. Mauriello, R. Gotti, E. Uliassi, M. L. Bolognesi, D. Rodríguez-Padrónae and R. Luque, Chem. Soc. Rev., 2021, 50, 11191–11207 RSC.
  53. The World Health Organisation World, Geneva: World Health Organisation, The malaria report 2021, https://www.who.int/publications/i/item/978924001571, accessed 6 nov 2025.
  54. (a) F. Lévesque and P. H. Seeberger, Angew Chem. Int. Ed. Engl., 2012, 51, 1706–1709 CrossRef PubMed; (b) D. Kopetzki, F. Lévesque and P. H. Seeberger, Chem.–Eur. J., 2013, 19, 5450–5456 CrossRef CAS PubMed; (c) J. Turconi, F. Griolet, R. Guevel, G. Oddon, R. Villa, A. Geatti, M. Hvala, K. Rossen, R. Göller and A. Burgard, Org. Process Res. Dev., 2014, 3, 417–422 CrossRef.
  55. (a) C. J. Paddon, P. J. Westfall, D. J. Pitera, K. Benjamin, K. Fisher, D. McPhee, M. D. Leavell, A. Taim, A. Main, D. Eng, D. R. Polichuk, K. H. Teoh, D. W. Reed, T. Treynor, J. Lenihan, M. Fleck, S. Bajad, G. Dang, D. Dengrove, D. Diola, G. Dorin, K. W. Ellens, S. Fickes, J. Galazzo, S. P. Gaucher, T. Geistlinger, R. Henry, M. Hepp, T. Horning, T. Iqbal, H. Jiang, L. Kizer, B. Lieu, D. Melis, N. Moss, R. Regentin, S. Secrest, H. Tsuruta, R. Vazquez, L. F. Westblade, L. Xu, M. Yu, Y. Zhang, L. Zhao, J. Lievense, P. S. Covello, J. D. Keasling, K. K. Reiling, N. S. Renninger and J. D. Newman, Nature, 2013, 496, 528–532 CrossRef CAS PubMed; (b) Z. Guo, Y. Zhou, J. Li, D. Liu, Y. Huang, Y. Zhang, R. Yu and J. Zhu, Nat. Commun., 2025, 16, 3888 CrossRef CAS PubMed.
  56. S. Liu, J. F. S. Ferreira, D. Tian, Y. Tang, L. Liu, W. Yang, Z. Liu and N. Tian, Chem. Pharm. Bull., 2018, 66, 319–326 CrossRef CAS PubMed.
  57. (a) N. M. Blebea, C. Puşcaşu, G. Hancu, A. M. Stăniguţ and C. Chiriţă, Pharmaceuticals, 2025, 18, 890 CrossRef CAS PubMed; (b) D. Duczmal, A. Bazan-Wozniak, K. Niedzielska and R. Pietrzak, Molecules, 2024, 29, 4923 Search PubMed.
  58. (a) J. Sastre-Garriga, C. Vila, S. Clissold and X. Montalban, Expert Rev. Neurother., 2011, 11, 627–637 CrossRef CAS PubMed; (b) V. Martínez, A. I. De-Hond, F. Borrelli, R. Capasso, M. D. del Castillo and R. Abalo, Int. J. Mol. Sci., 2020, 21, 3067 CrossRef PubMed.
  59. J. M. McPartland, Cannabis Cannabinoid Res., 2018, 3, 203–212 CrossRef CAS PubMed.
  60. (a) Y. C. Cheng and S. Kerrigan, Forensic Chem., 2024, 37, 100541 CrossRef CAS; (b) E. Small, Bot. Rev., 2015, 81, 189–294 CrossRef; (c) T. M. Attard, C. Bainier, M. Reinaud, A. Lanot, S. J. McQueen-Mason and A. J. Hunt, Ind. Crops Prod., 2018, 112, 38–46 CrossRef CAS.
  61. D. Harpaz, N. Bernstein, D. Namdar and E. Eltzov, Biotechnol. Adv., 2022, 61, 108031 CrossRef CAS PubMed.
  62. M. Mistry, S. Turumella, V. Prajapati and B. Z. Dholakiya, Bioresour. Technol. Rep., 2025, 30, 102126 CrossRef.
  63. J. Visković, V. D. Zheljazkov, V. Sikora, J. Noller, D. Latković, C. M. Ocamb and A. Koren, Agronomy, 2023, 13, 931 CrossRef.
  64. T. Fućak, S. Kreft, Ž. M. Svedružić and E. Tavčar, J. Plant Biochem. Biotechnol., 2023, 32, 608–621 CrossRef.
  65. D. Fiorini, A. Molle, M. Nabissi, G. Santini, G. Benelli and F. Maggi, Ind. Crops Prod., 2019, 128, 581–589 CrossRef CAS.
  66. C. M. Eiroa Martínez, D. Van Houten, M. V. Fernández Cid and G. Feye Woerlee, WO Pat., WO2016153347A1, 2016 Search PubMed.
  67. R. Pertile and T. Black, U.S. Pat., US10561693B2, 2020 Search PubMed.
  68. S. Marzorati, D. Friscione, E. Picchi and L. Verotta, Ind. Crops Prod., 2020, 155, 112816 CrossRef CAS.
  69. R. Calmanti, M. Selva and A. Perosa, ACS Agric. Sci. Technol., 2025, 5, 346–354 CrossRef CAS PubMed.
  70. K. J. Olejar, J. Hatfield, C. J. Arellano, A. T. Gurau, D. Seifried, B. V. Heuvel and C. A. Kinney, Ind. Crops Prod., 2021, 170, 113771 CrossRef CAS.
  71. V. Verardo, A. M. Gómez-Caravaca, E. Marconi, A. Segura-Carretero, A. Garrido-Frenicha and A. Fernández-Gutiérrez, RSC Adv., 2016, 6, 50786–50796 Search PubMed.
  72. (a) W. Teng, Z. Zhou, J. Cao and Q. Guo, Foods, 2024, 13, 2226 CrossRef CAS PubMed; (b) L. R. Zeng, B. W. Pan, J. Cai, L. J. Liu, Z. C. Dong, Y. Zhou, T. T. Feng and Y. Shi, RSC Adv., 2024, 14, 39436–39461 RSC; (c) B. E. Rivero-Chan, J. G. Marrero, S. Hernández-Ortega, G. J. Mena-Rejón and L. D. Miranda, Nat. Prod. Res., 2012, 26, 675–679 Search PubMed; (d) O. Z. Olatunde, J. Yong, D. Tiand and C. Lu, Org. Biomol. Chem., 2025, 23, 5929–6051 Search PubMed.
  73. L. A. Contreras-Angulo, H. Laaroussi, D. Ousaaid, M. Bakour, B. Lyoussi and P. Ferreira-Santos, J. Food Sci., 2025, 90, e70412 CrossRef CAS PubMed.
  74. S. Agatonovic-Kustrin, V. Gegechkori, E. U. R. Mohammed, H. Ku and D. W. Morton, Appl. Sci., 2022, 12, 996 CrossRef CAS.
  75. J. Velasco, F. Holgado, G. Márquez-Ruiz and M. V. Ruiz-Méndez, J. Sci. Food Agric., 2018, 98, 4837–4844 CrossRef CAS PubMed.
  76. L. Antoniadi, A. Angelis, T. Nikou, D. Michailidis and L. A. Skaltsounis, Molecules, 2025, 30, 2709 CrossRef CAS PubMed.
  77. I. Gómez-Cruz, M. M. Contreras, I. Romero and E. Castro, Foods, 2022, 11, 2002 CrossRef PubMed.
  78. P. Xie, L. Huanga, C. Zhanga, Y. Denga, X. Wanga and J. Cheng, Food Chem., 2019, 276, 662–674 CrossRef CAS PubMed.
  79. F. S. P. P. Neto, I. U. M. Roldán, J. P. M. Galán, R. Monti, S. C. de Oliveira and F. Masarin, Ind. Crops Prod., 2020, 154, 112707 CrossRef CAS.
  80. C. S. D. Oliveira, P. Moreira, M. T. Cruz, C. M. F. Pereira, A. Gaspar, C. P. Neto, P. C. R. O. Pinto, P. C. Branco, A. M. S. Silva, S. A. O. Santos and A. J. D. Silvestre, RSC Sustainability, 2023, 1, 1016–1024 RSC.
  81. (a) B. B. Hansen, S. Spittle, B. Chen, D. Poe, Y. Zhang, J. M. Klein, A. Horton, L. Adhikari, T. Zelovich, B. W. Doherty, B. Gurkan, E. J. Maginn, A. Ragauskas, M. Dadmun, T. A. Zawodzinski, G. A. Baker, M. E. Tuckerman, R. F. Savinell and J. R. Sangoro, Chem. Rev., 2021, 121, 1232–1285 CrossRef CAS PubMed; (b) C. Siripattanakulkajorn, P. Sombutsuwan, P. Villeneuve, B. Baréa, K. Aryusuk and E. Durand, ACS Food Sci. Technol., 2024, 4, 2462–2473 CrossRef CAS.
  82. N. H. C. S. Silva, E. S. Morais, C. S. R. Freire, M. G. Freire and A. J. D. Silvestre, Molecules, 2020, 25, 210 CrossRef CAS PubMed.
  83. L. Huang, Y. Guo, T. Jin, K. Yan, X. Liu, S. He, L. Li, Y. Gong, J. Ma, H. Yu, Z. Lu, Y. Liu, W. Dong and F. Yang, J. Cleaner Prod., 2023, 427, 139274 CrossRef CAS.
  84. H. Li, Y. Liu, S. Guo, M. Shi, S. Qin and C. Zeng, Foods, 2023, 12, 310 CrossRef CAS PubMed.
  85. F. Errichiello, R. Cucciniello, M. Tomasini, L. Falivene, A. Gambuti, C. Cassiano and M. Forino, Green Chem., 2024, 26, 10177–10188 RSC.
  86. E. L. P. de Faria, S. V. Shabudin, A. F. M. Claúdio, M. Válega, F. M. J. Domingues, C. S. R. Freire, A. J. D. Silvestre and M. G. Freire, ACS Sustain. Chem. Eng., 2017, 5, 7344–7351 CrossRef CAS PubMed.
  87. (a) S. Zio, B. Tarnagda, F. Tapsoba, C. Zongo and A. Savadogo, Heliyon, 2024, 10, e40132 CrossRef PubMed; (b) X. Chen, L. S. M. Kunda, X. Li, N. Wang, Y. Huang, Y. Hao, Q. He, W. Liao and J. Chen, J. Agric. Food Chem., 2025, 73, 3826–3841 CrossRef CAS PubMed; (c) M. Shen, L. Yuan, J. Zhang, X. Wang, M. Zhang, H. Li, Y. Jing, F. Zeng and J. Xie, Foods, 2024, 13, 1754 CrossRef CAS PubMed; (d) A. Poli, F. Marangoni, A. Corsini, E. Manzato, W. Marrocco, D. Martini, G. Medea and F. Visioli, Nutrients, 2021, 13, 2810 CrossRef CAS PubMed.
  88. Udaypal, R. K. Goswami, S. Mehariya and P. Verma, Sustainable Chem. Pharm., 2024, 42, 101791 CrossRef CAS.
  89. (a) N. Z. Abdul Kapor, G. P. Maniam, M. H. A. Rahim and M. M. Yusoff, J. Cleaner Prod., 2017, 143, 1–9 CrossRef CAS; (b) L. J. Visioli, F. de Castilhos, L. Cardozo-Filho, B. T. F. de Mello and C. da Silva, Fuel Process. Technol., 2016, 149, 326–331 CrossRef CAS; (c) H. Yang, F. Yan, D. Wu, M. Huo, J. Li, Y. Cao and Y. Jiang, Bioresour. Technol., 2010, 101, 1471–1476 CrossRef CAS PubMed.
  90. A. Bouriakova, P. S. F. Mendes, K. Elst, J. De Clercq and J. W. Thybaut, Chem. Eng. Res. Des., 2020, 154, 122–134 CrossRef CAS.
  91. (a) P. J. Asl, R. Niazmand and F. Yahyavi, Heliyon, 2020, 6, e03592 CrossRef PubMed; (b) P. J. Asl, R. Niazmand and M. Jahani, J. Food Eng., 2020, 269, 109748 CrossRef.
  92. H. Yang, F. Yan, D. Wu, M. Huo, J. Li, Y. Cao and Y. Jiang, Bioresour. Technol., 2010, 101, 1471–1476 CrossRef CAS PubMed.
  93. M. M. Alonso, R. H. Soto, M. C. Rodríguez, C. S. Hernández, J. M. M. Miranda, J. F. V. Alcaraz and J. G. Marrero, RSC Adv., 2022, 12, 23747–23753 RSC.
  94. Y. Shimada, S. Nakai, M. Suenaga, A. Sugihara, M. Kitano and Y. Tominag, J. Am. Oil Chem. Soc., 2000, 77, 1009–1013 CrossRef CAS.
  95. Y. Watanabe, T. Nagao, Y. Hirota, M. Kitano and Y. Shimada, J. Am. Oil Chem. Soc., 2004, 81, 339–345 CrossRef CAS.
  96. C. F. Torres, G. Torrelo, F. J. Senorans and G. Reglero, Process Biochem., 2007, 42, 1335–1341 CrossRef CAS.
  97. W. Lv, C. Wu, S. Lin, X. Wang and Y. Wang, ACS Omega, 2021, 6, 9141–9152 CrossRef CAS PubMed.
  98. Q. Xue, Z. Yu, Y. Wang, C. Zhang, Y. Guo, M. Cao, M. Chang and R. Liu, Food Bioprocess Technol., 2025, 18, 7254–7266 CrossRef CAS.
  99. E. Pérez-Botella, S. Valencia and F. Rey, Chem. Rev., 2022, 122, 17647–17695 CrossRef PubMed.
  100. O. Karaoglu, G. Alpdogan, S. D. Zor, H. Bildirir and E. Ertas, Food Chem., 2020, 311, 125890 CrossRef CAS PubMed.
  101. (a) S. B. Nimse and D. Pal, RSC Adv., 2015, 5, 27986–28006 RSC; (b) M. Rahaman, R. Hossain, J. Herrera-Bravo, M. T. Islam, O. Atolani, O. S. Adeyemi, O. A. Owolodun, L. Kambizi, S. D. Daştan, D. Calina and J. Sharifi-Rad, Food Sci. Nutr., 2023, 11, 1657–1670 CrossRef PubMed; (c) B. Parveen, V. Rajinikanth and M. Narayanan, Discover Appl. Sci., 2025, 7, 845 CrossRef CAS; (d) S. C. Lourenço, M. Moldão-Martins and V. D. Alves, Molecules, 2019, 24, 4132 CrossRef PubMed.
  102. (a) M. Macías-Alonso, L. S. Andrés, I. Córdova-Guerrero, A. Estolano-Cobián, L. Díaz-Rubio and J. G. Marrero, Nat. Prod. Res., 2021, 35, 2972–2976 CrossRef PubMed; (b) Z. Sargazifar, D. G. Charami, M. E. Kashi, J. Asili and A. Shakeri, Chem. Biodiversity, 2024, 21, e202400808 CrossRef CAS PubMed.
  103. (a) H. Guan, W. Luo, B. Bao, Y. Cao, F. Cheng, S. Yu, Q. Fan, L. Zhang, Q. Wu and M. Shan, Molecules, 2022, 27, 3292 CrossRef CAS PubMed; (b) S. Noor, T. Mohammad, M. A. Rub, A. Raza, N. Azum, D. K. Yadav, I. Hassan and A. M. Asiri, Arch. Pharmacal Res., 2022, 45, 205–228 CrossRef CAS PubMed.
  104. (a) J. G. Marrero, L. Moujir, L. San Andrés, N. P. Montaño, L. Araujo and J. G. Luis, J. Nat. Prod., 2009, 72, 1385–1389 CrossRef CAS PubMed; (b) C. Mantzourani, P. A. Tarantilis and M. G. Kokotou, Separations, 2023, 10, 481 CrossRef CAS; (c) M. Macías Alonso, L. S. Andrés and J. G. Marrero, Tetrahedron Lett., 2024, 153, 155362 CrossRef.
  105. (a) S. Christaki, E. Bouloumpasi, E. Lalidou, P. Chatzopoulou and M. Irakli, Molecules, 2022, 27, 9058 CrossRef CAS PubMed; (b) I. Ziani, H. Bouakline, M. Merzouki, M. L. Fauconnier, F. Sher, N. E. Bentouhami, A. Asehraou and A. El Bachiri, Ind. Crops Prod., 2025, 223, 120125 CrossRef CAS.
  106. X. Chen, Q. Luo, W. Hu, J. Chen and R. Zhang, Ind. Crops Prod., 2022, 177, 114441 CrossRef CAS.
  107. M. Loussouarn, A. Krieger-Liszkay, L. Svilar, A. Bily, S. Birtić and M. Havaux, Plant Physiol., 2017, 175, 1381–1394 CrossRef CAS PubMed.
  108. (a) E. V. Sánchez, M. M. Alonso, S. O. Robles, L. H. Isidrón, H. N. Palenius and J. G. Marrero, Pharmaceuticals, 2021, 14, 747 CrossRef PubMed; (b) N. Villa-Ruano, N. Hernández-Silva, J. Leocadio Varela-Caselis, S. Alberto-Ramirez-Garcia and C. Mosso-González, Chem. Biodiversity, 2023, 20, e202200733 CrossRef CAS PubMed; (c) U. Scheler, W. Brandt, A. Porzel, K. Rothe, D. Manzano, D. Božić, D. Papaefthimiou, G. U. Balcke, A. Henning, S. Lohse, S. Marillonnet, A. K. Kanellis, A. Ferrer and A. Tissier, Nat. Commun., 2016, 7, 12942 CrossRef CAS PubMed.
  109. J. G. Marrero, L. San Andrés and J. G. Luis, J. Nat. Prod., 2002, 65, 986–989 CrossRef CAS PubMed.
  110. S. Kim, E. J. Yun, J. S. Bak, H. Lee, S. J. Lee, C. T. Kim, J. H. Lee and K. H. Kim, Food Chem., 2010, 121, 521–526 CrossRef CAS.
  111. J. H. Zhang, M. Zhang, B. Q. Bai, H. W. Jia and S. H. Fan, J. Oleo Sci., 2021, 70, 439–451 CrossRef CAS PubMed.
  112. C. Sciacca, N. Cardullo, M. Savitteri, M. G. G. Pittalà, L. Pulvirenti, E. M. Napoli and V. Muccilli, Molecules, 2025, 30, 1391 CrossRef CAS PubMed.
  113. S. Nasrallah and M. Minceva, Pharmaceutics, 2025, 22, 1408–1418 CAS.
  114. D. Tripathi, N. Chaudhary, P. Wal, A. K. Rai and J. Sahoo, Drug Delivery Lett., 2021, 11, 220–232 CrossRef CAS.
  115. A. Mazaud, R. Lebeuf, C. Pierlot, M. Laguerre and V. Nardello-Rataj, ACS Sustainable Chem. Eng., 2021, 9, 4801–4811 CrossRef CAS.
  116. (a) A. Mazaud, R. Lebeuf, M. Laguerre and V. Nardello-Rataj, ACS Sustainable Chem. Eng., 2020, 8, 15268–15277 CrossRef CAS; (b) A. Mazaud, R. Lebeuf, M. Laguerre and V. Nardello-Rataj, ACS Sustainable Chem. Eng., 2022, 10, 3673–3681 CrossRef CAS.
  117. M. Jakovljević, S. Jokić, M. Molnar and I. Jerković, Plants, 2021, 10, 80 CrossRef PubMed.
  118. M. Boufetacha, A. Ayad, N. Thiebault, N. Boussetta, E. Gharibi and M. Benali, J. Supercrit. Fluids, 2024, 212, 106344 CrossRef CAS.
  119. T. Wang, Q. Guo, P. Li and H. Yang, Food Chem., 2022, 390, 133225 CrossRef CAS PubMed.
  120. C. Vieira, S. Rebocho, R. Craveiro, A. Paiva and A. R. C. Duarte, Front. Chem., 2022, 10, 954835 CrossRef CAS PubMed.
  121. C. Zhu, Y. Fan and H. Wu, Molecules, 2023, 28, 5493 CrossRef CAS PubMed.
  122. C. Zhu, Y. Fan and X. Bai, Foods, 2023, 12, 1761 CrossRef CAS PubMed.
  123. C. J. Mo, Y. Q. Xu, Y. Feng, A. J. Chen, C. W. Yang and H. Ni, Ind. Crops Prod., 2022, 187, 115448 CrossRef CAS.
  124. K. Pyrzynska, Nutrients, 2022, 14, 2387 CrossRef CAS PubMed.
  125. I. Mssillou, M. Bakour, M. Slighoua, H. Laaroussi, H. Saghrouchni, F. Ez-Zahra Amrati, B. Lyoussi and E. Derwich, J. Ethnopharmacol., 2022, 298, 115663 CrossRef CAS PubMed.
  126. D. Stanisic, L. H. B. Liu, R. V. dos Santos, A. F. Costa, N. Durán and L. Tasic, Molecules, 2020, 25, 4534 CrossRef CAS PubMed.
  127. M. M. Victor, J. M. David, M. V. M. Cortez, J. L. Leite and G. S. B. da Silva, Waste Biomass Valorization, 2021, 12, 313–320 CrossRef CAS.
  128. S. Selim, M. Albqmi, M. M. Al-Sanea, T. S. Alnusaire, M. S. Almuhayawi, H. AbdElgawad, S. K. Al Jaouni, A. Elkelish, S. Hussein, M. Warrad and M. T. El-Saadony, Front. Nutr., 2022, 9, 1008349 CrossRef PubMed.
  129. A. Mir-Cerdà, M. Granados, J. Saurina and S. Sentellas, Food Chem., 2024, 456, 140042 CrossRef PubMed.
  130. E. Boli, N. Prinos, V. Louli, G. Pappa, H. Stamatis, K. Magoulas and E. Voutsas, Separations, 2022, 9, 255 CrossRef CAS.
  131. L. Baldino, G. Della Porta, L. Sesti Osseo, E. Reverchon and R. Adami, J. Supercrit. Fluids, 2018, 133, 65–69 CrossRef CAS.
  132. C. Chinnarasu, A. Montes, C. Pereyra, C. L. C. Pereyra, M. T. Fernández-Ponce, C. Mantell, S. Pattabhi and E. M. de la Ossa, Korean J. Chem. Eng., 2016, 33, 594–602 CrossRef CAS.
  133. S. Topuz and M. Bayram, J. Food Process. Preserv., 2022, 46, e15697 CAS.
  134. A. Dobrinčić, M. Repajić, I. E. Garofulić, L. Tuđen, V. Dragović-Uzelac and B. Levaj, Processes, 2020, 8, 1008 CrossRef.
  135. G. S. Da Rosa, S. K. Vanga, Y. Gariepy and V. Raghavan, Innovative Food Sci. Emerging Technol., 2019, 58, 102234 CrossRef.
  136. A. Lama-Muñoz, M. M. Contreras, F. Espínola, M. Moya, I. Romero and E. Castro, Energies, 2019, 12, 2486 CrossRef.
  137. D. Cör Andrejč, B. Butinar, Ž. Knez, K. Tomažič and M. Knez Marevci, Plants, 2022, 11, 865 CrossRef PubMed.
  138. A. Lama-Muñoz, M. M. Contreras, F. Espínola, M. Moya, A. de Torres, I. Romero and E. Castro, Food Chem., 2019, 293, 161–168 CrossRef PubMed.
  139. A. Tremblay, H. Arguin and S. Panahi, Int. J. Obes., 2016, 40, 1198–1204 CrossRef CAS PubMed.
  140. J. Zhao, C. Jiang, M. Lei, Y. Xie, J. Zhao, J. Chen, M. Yang, D. Xiang, J. Tang and H. Lin, Food Chem., 2025, 472, 142992 CrossRef CAS PubMed.
  141. A. F. Barbosa, M. G. de Carvalho, R. E. Smith and A. U. O. Sabaa-Srur, Rev. Bras. Farmacogn., 2016, 26, 128–133 CrossRef CAS.
  142. J. Martínez, J. Rosas, J. Pérez, Z. Saavedra, V. Carranza and P. Alonso, Nat. Prod. Res., 2019, 33, 447–452 CrossRef PubMed.
  143. P. P. Zhao, Y. M. Lu, C. P. Tan, Y. Liang and B. Cui, Appl. Biochem. Biotechnol., 2015, 175, 1018–1034 CrossRef CAS PubMed.
  144. Y. Fan, Y. M. Lu, B. Yu, C. P. Tan and B. Cui, J. Chromatogr. B:Anal. Technol. Biomed. Life Sci., 2017, 1063, 11–17 CrossRef CAS PubMed.
  145. (a) F. Alperth, T. Feistritzer, M. Huber, O. Kunert and F. Bucar, Molecules, 2024, 29, 612 CrossRef CAS PubMed; (b) F. Alperth, S. Erhart, O. Kunert and F. Bucar, Separations, 2024, 11, 251 CrossRef CAS.
  146. M. Grymel, R. Mazurkiewicz, S. Bajkacz, J. Bilik and S. Kowalczyk, Planta Med., 2023, 89, 551–560 CrossRef CAS PubMed.
  147. N. E. C. Cienfuegos, P. L. Santos, A. R. García, C. M. F. Soares, A. S. Lima and R. L. Souza, Food Bioprod. Process., 2017, 106, 1–10 CrossRef CAS.
  148. A. A. A. Aioub, S. Ghosh, A. AL-Farga, A. N. Khan, R. Bibi, A. M. Elwakeel, A. Nawaz, N. T. Sherif, S. A. Elmasry and E. E. Ammar, Eur. J. Plant Pathol., 2024, 169, 697–713 CrossRef.
  149. A. K. Priya, A. Alagumalai, D. Balaji and H. Song, RSC Sustainability, 2023, 1, 746–762 RSC.
  150. A. L. Souto, M. Sylvestre, E. D. Tölke, J. F. Tavares, J. M. Barbosa-Filho and G. Cebrián-Torrejón, Molecules, 2021, 26, 4835 CrossRef CAS PubMed.
  151. W. Li, N. Wang, J. Liu, Y. Ma, Q. Wang, W. Li, Y. Mu, Q. Wu and C. Wang, J. Future Foods, 2026, 6, 730–739 CrossRef.
  152. Y. S. Shia, Y. Zhang, H. T. Lia, C. H. Wud, H. R. El-Seedie, W. K. Yed, Z. W. Wangd, C. B. Lia, X. F. Zhangc and G. Y. Kaib, J. Future Foods, 2020, 75, 104213 Search PubMed.
  153. (a) X. Huang, T. Li, X. Shan, R. Lu, M. Hao, M. Lv, Z. Sun and H. Xu, J. Agric. Food Chem., 2020, 68, 12241–12251 CrossRef CAS PubMed; (b) C. Yang, Y. F. Li, Q. Hu, H. C. Shi, J. Q. Duan, M. T. He, H. Cao and X. Y. Zhi, Ind. Crops Prod., 2024, 220, 119215 CrossRef CAS.
  154. (a) B. S. Patil, J. Yu, D. V. Dandekar, R. T. Toledo, R. K. Singh and L. M. Pike, ACS Symp. Ser., 2006, 936, 18–33 CrossRef CAS; (b) G. K. Jayaprakasha, J. S. Brodbelt, N. G. Bhat and B. S. Patil, ACS Symp. Ser., 2006, 936, 34–51 CrossRef CAS.
  155. D. V. Dandekar, G. K. Jayaprakasha and B. S. Patil, Z. Naturforsch., C:J. Biosci., 2008, 63, 176–180 CrossRef CAS PubMed.
  156. J. Y. Lim, H. S. Yoon, K. Y. Kim, K. S. Kim, J. G. Noh and I. G. Song, Food Sci. Biotechnol., 2010, 19, 1135–1142 CrossRef CAS.
  157. J. R. Ramos-Ibarra, E. Arriola-Guevara, G. Toriz, G. Guatemala-Morales and R. I. Corona-Gonzalez, Rev. Mex. Ing. Quim., 2021, 20, 1–13,  DOI:10.24275/rmiq/Bio2404.
  158. J. S. Martinez-Fernandez, X. Gu and S. Chen, J. Cleaner Prod., 2021, 282, 124356 CrossRef CAS.
  159. M. Orive, M. Cebrián, J. Amayra, J. Zufía and C. Bald, Process Saf. Environ. Prot., 2021, 147, 924–931 CrossRef CAS.
  160. B. Zeng, L. Chen, S. Zhai, K. Chen, Z. Pan, L. Yang, N. A. Khan, K. Zuo and H. Zhu, Chem. Eng. J., 2025, 522, 167425 CrossRef CAS.
  161. (a) D. P. Zagklis, C. S. Papageorgiou and C. A. Paraskeva, Sustainability, 2021, 13, 2376 CrossRef CAS; (b) Á. Mayor, S. Vinardell, K. Ganesan, C. Bacardí, J. L. Cortina and C. Valderrama, Sci. Total Environ., 2023, 892, 164452 CrossRef PubMed.
  162. X. Zhang and M. Thomsen, Algal Res., 2021, 60, 102499 CrossRef.
  163. A. Lapkin, E. Adou, B. N. Mlambo, S. Chemat, J. Suberu, A. E. C. Collis, A. Clark and G. Barker, C. R. Chim., 2014, 17, 232–241 CrossRef CAS.
  164. M. Lohrasbi, M. Pourbafrani, C. Niklasson and M. J. Taherzadeh, Bioresour. Technol., 2010, 101, 7382–7388 CrossRef CAS PubMed.
  165. J. del Amo, I. Izarra, M. Arriaga, J. Vicente, F. J. Pinar, A. Hamdi, R. Guillén-Bejarano and J. Mena, Biofuels, Bioprod. Biorefin., 2025, 19, 1349–1363 CrossRef CAS.
  166. P. V. Almeida, L. M. Gando-Ferreira and M. J. Quina, Foods, 2024, 13, 1873 CrossRef CAS PubMed.
  167. (a) K. A. Nandeshwar, S. M. Kodape and A. P. Rathod, Ind. Eng. Chem. Res., 2024, 63(39), 16801–16813 CrossRef CAS; (b) T. Hatami and O. N. Ciftci, J. Food Eng., 2023, 357, 111639 CrossRef CAS.
  168. J. A. Becerra and A. L. Villa, Chem. Eng. Technol., 2020, 43, 2295–2306 CrossRef CAS.
  169. V. M. Santos, V. M. A. Calado and N. Bojorge, Biofuels, Bioprod. Biorefin., 2022, 16, 962–971 CrossRef CAS.
  170. M. Ortiz-Sánchez, J. C. Solarte-Toro, P. J. Inocencio-García and C. A. Cardona Alzate, Enzyme Microb. Technol., 2024, 172, 110327 CrossRef PubMed.
  171. G. L. Zabot, M. N. Moraes, P. I. N. Carvalho and M. A. A. Meireles, Ind. Crops Prod., 2015, 77, 758–771 CrossRef CAS.

This journal is © The Royal Society of Chemistry 2026
Click here to see how this site uses Cookies. View our privacy policy here.